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Stress do Retículo Endoplasmático Transmissível, células 
tumorais, mecanismos de imunoevasão, células dendríticas, 
exossomas 
Resumo 
 
 
O cancro da mama é o cancro de maior incidência 
entre as mulheres, sendo também uma das situações 
oncológicas que mais mortes causa. Na última década 
inúmeros estudos têm demonstrado que os tumores sólidos 
geram um microambiente favorável à evasão/subversão do 
sistema imune. Esse microambiente (acidose, hipoxia, 
deprivação de glucose, citoquinas) é muita das vezes propicio 
à indução de stress do reticulo endoplasmático (RE). O stress 
do RE é primariamente uma resposta no sentido de 
restabelecer a homeostasia no entanto se não resolvido 
resulta normalmente na morte celular por apoptose. O stress 
do RE e a respetiva resposta às proteínas mal conformadas 
(UPR), desempenham um papel paradoxal na fisiopatologia 
do cancro: os três ramos da UPR, PERK, IRE1 e ATF6, 
contribuem ativamente para a sinalização de alguns 
mecanismos de sobrevivência e metastização. Recentemente, 
foi descrita uma possível transmissão do stress do RE das 
células tumorais para as células do sistema imunitário, 
modulando a ação destas. Desta forma, pretendeu avaliar-se 
com o presente trabalho a capacidade e os mecanismos pelos 
quais células tumorais T-47D transmitem o stress do RE para 
células monocíticas THP-1, e quais as consequências desta 
transmissão. A transmissão foi apenas observada aquando da 
utilização de indutores farmacológicos como a tunicamicina, 
não se registando para estímulos fisiológicos como a 
deprivação de glucose. Por outro lado, verificou-se que a 
tunicamicina parece ser transportada via exossomas e desta 
forma induzir diretamente stress do RE nos monócitos. 
Observou-se ainda que os exossomas provenientes das 
células T-47D em stress do RE por deprivação de glucose 
apesar de não transmitirem o referido stress conduzem os 
monócitos para um perfil pró-inflamatório específico 
diminuindo ainda a sua capacidade de maturação. Em geral, 
os nossos resultados questionam seriamente o mecanismo de 
transmissão de stress ER tal como originalmente descrito, 
mostrando que no uso de indutores farmacológicos o que 
parece ocorrer é o transporte do fármaco em vesículas e a 
indução direta nas células recetoras.  
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Abstract 
 
 
Breast cancer is the most prevalent cancer among women and 
also one of the oncologic pathologies that causes more 
deaths. In the last decades several studies have reported that 
solid tumors generate an immunosuppressive 
microenvironment. This microenvironment (acidosis, hypoxia, 
glucose deprivation and cytokines) is favourable to 
endoplasmic reticulum (ER) stress induction. ER stress is 
primarily a response towards the re-establishment of 
homeostasis; however if not resolved it usually results in cell 
death by apoptosis. Nevertheless, ER stress and unfolded 
protein response (UPR) play a paradoxical role in cancer 
physiopathology: the three branches of UPR, PERK, IRE1 and 
ATF6 actively contribute to signalling of survival and 
metastasis mechanisms. Recently it was reported a possible 
transmission of ER stress from tumor cells to immune cells, 
modulating the phenotype and function of recipient cells. Thus, 
the aim of the present work is to assess the ability and the 
respective mechanisms by which T-47D tumor cells transmit 
ER stress to THP-1 monocytes, and the consequences of this 
transmission. ER stress transmission was only observed when 
pharmacological ER stress inducers were used, such as 
tunicamycin, contrarily to physiological stimulation, as glucose 
deprivation. Additionally, it was found that tunicamycin seems 
to be transported within exosomes which, in turn, directly 
induces ER stress on monocytes. It was also observed that 
exosomes derived from glucose deprived T-47D cells do not 
transmit ER stress; however these exosomes conduct 
monocytes towards a particular proinflammatory profile, 
accompanied by the decrease of its maturation status. Overall, 
our results question the ER stress mechanism originally 
described, showing that pharmacological ER stress inducers 
can be transported within exosomes and directly inducing ER 
stress on recipient cells.  
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Introduction  
1. Cancer  
Cancer is one of the leading causes of death, accounting for about 13% of all deaths 
in the world in 2008 [1]. Actually, about 70% of worldwide cancer-related deaths are in 
low and middle-income countries given that, in developed countries, the easiest access to 
innovative therapies greatly contributes to lower the mortality [1]. Cancer is the common 
designation for a family of diseases characterized by the uncontrolled growth of cells from 
some tissue, resulting in a loss of differentiation and altered control of cell cycle. However, 
this condition is only called as cancer when the growing tumor has a malignant character. 
Malignancy is characterized by loss of cell aggregative capacities, where cells detach from 
the extracellular matrix and spread to other body organs. These malignant cells, when they 
metastasize, will influence the correct growth, differentiation and metabolism of other cells 
and tissues, and, because of that, the tumor will be held not only at the origin site, but all 
over the body, including vital organs [2]. 
The leading cause of this abnormal cell transformation was traditionally studied as a 
genetic issue. Mutations are common in some proliferative-regulatory genes, such as  
proto-oncogenes (growth factors, receptors, signal transducers, transcription factors, 
cyclins) responsible for the progression of the cell cycle, tumor suppressors (transforming  
growth factor - β (TGF-β), E-caderin, β-catenin, p53, BRCA1 and BRCA2), and apoptosis-
regulatory genes [3]. Therefore, during many years researchers focused their work on the 
fact that the loss of control was only result from genetic somatic mutations, and 
experiments were mainly performed using only purified malignant cells (either primary or 
established cell lines). However, over the last 15 years 
 
the studies started to focus on the 
influence of surrounding stromal cells on the breast carcinoma behaviour (reviewed in [4]). 
This opened a new vision to the cancer research: the tumor microenvironment contribution. 
Thus, the cellular proliferation is not an intrinsic process by itself, as surrounding cells also 
contribute to the tumor modulation, by releasing cytokines, chemokines, inflammatory 
mediators and extracellular enzymes, such as matrix metalloproteinases (reviewed in [4]).  
The tumor mass is composed not only by these abnormal proliferating cells but by a pool 
of other cell types as immune cells (macrophages, mast cell, neutrophils, natural killer cells 
(NK cells), myeloid-derived suppressor cells (MDSC), dendritic cells (DC), B and T 
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lymphocytes) and stromal cells as fibroblasts, mesenchymal and endothelial cells. The 
tumor microenvironment is also very rich in soluble factors such as growth factors, 
cytokines and chemokines, molecules of upmost importance in the intercellular 
communication, particularly to tumor-stromal cells [5]. The expression and secretion of 
these factors is a potent way by which tumor cells can control their growth or death, 
depending on the balance between pro- and anti-inflammatory signals. Moreover, tumor 
microenvironment is also characterized by its particular and extreme conditions. The 
abnormal fast proliferation of cancer cells, results in an insufficient perfusion of oxygen, 
glucose or amino acids and inefficient clearance of the toxic cell products such as lactate, 
and carbon dioxide (CO2). Cancer cells, characterized by the high capacity to adapt to the 
most noxae conditions, redirect their metabolic processes in order to obtain energy in low 
pO2: the ATP production is mainly via glycolytic-lactate pathway [6]. Additionally to this 
environmental adaptation, researchers have also reported a specific feature of metabolism 
on these tumor cells: the Warburg effect. Warburg effect is observed in tumor cells that, 
even in normoxic conditions, produce ATP by glycolysis-lactate pathway. This process is 
explained by the dysfunction observed in cancer cells mitochondria, resulting from the 
action of high level of ROS in the tumor [7–9]. Thus, even if less efficient, the tumor cell 
is able to continue producing energy and substrates for nucleic acid, protein and fatty acid 
synthesis in hypoxia conditions and in a quicker way, enabling the overwhelming 
proliferation process. In this process several transcription factors, such as hypoxia-
inducible factors (HIF-1) pay a central role. HIF-1, is activated either by hypoxia or by 
oncongenic pathways already activated like PI3K or mutations in tumor suppressor 
proteins such as von Hippel-Lindau (VHL) [10]. When activated, HIF-1 promotes the 
transcription of pyruvate dehydrogenase kinase (PDK) which in turn, will inhibit PD, 
preventing the formation of acetyl-CoA in the mitochondria and redirecting the glycolytic 
pathway through the lactate final product [11]. Moreover, activated HIF-1 also induces the 
transcription of GLUT-family transporters, which facilitate glucose import to the cell, 
providing more energy substrate [7]. 
 
1.1. Breast Cancer 
Breast Cancer (BC) is the most frequent cancer in women (22,9% of all cancers) but 
if diagnosed and treated on time, a woman has a 90% chance to be cured [1]. This type of 
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cancer is characterized by a solid malignant tumor, and can be classified as invasive and 
non-invasive (in situ). In situ mammary carcinoma is designed when the tumor is in its 
initial stage, when there is no evidence of invasion of these tumor cells on other tissues 
(metastasis) or disorganization of myoepithelial cell layers and basement membrane [12]. 
Apart from that, breast cancer can be distinguished also by its origin: ductal (when it is 
developed from the inner lining of milk ducts) or lobular (when the tumor originating cells 
are from lobules that supply ducts with milk) [2]. The most common breast cancer is the 
ductal carcinoma in situ (DCIS), which isn't life-threatening, but may increase the chance 
to suffer from invasive cancer in some years from the initial diagnosed form [13]. The 
characterization and selection of a breast cancer cell line model has a great importance and 
relevance to the study and comprehension of physiopathological mechanisms and 
development of more efficient therapeutics on breast cancer. The classification of these 
cell lines (Table 1) is based on their phenotypic profile, mainly their estrogen and 
progesterone receptor expression, but also human epidermal growth factor receptor 2 
(HER2) [14]. The BC cell lines commonly used are MCF-7 and T-47D, due to their 
hormone responsiveness (positive to both estrogen and progesterone receptors). 
 
Table 1 - Breast cancer cell lines classification by its respective phenotypic profile (estrogen receptor 
(ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2). Adapted 
from [14]. 
 
Classification Immunoprofile Ligand Responsiveness  
Cell lines 
example 
Luminal A 
ER
+
, PR
+/-
, 
HER2
-
 
Endocrine responsive 
MCF-7, T-47D, 
SUM185 
Luminal B 
ER
+
, PR
+/-
, 
HER2
+
 
Endocrine and Trastuzumab responsive BT474, ZR-75 
Basal 
ER
-
, PR
-/-
, 
HER2
-
 
Endocrine nonresponsive, most aggressive 
cancer type (high proliferative rate and 
metastatic behaviour) 
MDA-MB-468, 
SUM190 
HER2 
enriched 
ER
-
, PR
-/-
, 
HER2
+
 
Endocrine nonresponsive but Trastuzumab 
responsive 
SKBR3, MDA-
MB-453 
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 These cell lines are therefore recognized by some specific tumor markers, and by 
their secretion and phenotypic profile. For instance, steroid receptors, as progesterone (PR) 
and estrogen receptors (ER), are among the most common tumor biomarkers. These two 
endocrine receptors can be overexpressed in some particular BC cell lines, as luminal A 
and luminal B, and when bound to its ligands (17β-estradiol or progesterone, respectively) 
they promote cell growth and proliferation [15]. This fact opened some hope to endocrine 
therapies with the aim to inhibit these two receptors and researchers have developed 
estrogen receptor antagonists such as tamoxifen. In some more specific cases, as in HER2
+ 
cells, HER2 is a specific receptor with tumor biomarker properties. It is expressed in 25-
30% of breast cancer cases, and one inhibitor was developed and shown to stop tumor 
growth and progression, trastuzumab. Trastuzumab is a monoclonal antibody, developed to 
bind with high affinity to HER2, preventing the activation of different pathways associated 
with the cell proliferation and anti-apoptotic mechanisms [16]. Another two important 
proteins that must be highlighted are E-cadherin and cathepsin-D, related to the stromal-
epithelium interactions. Cathepsin is an oestrogen-induced lysosomal protease which has 
mitogenic activity on ER-positive breast cancer cell lines and a proteolytic activity on 
basement membranes and proteoglycans. This protein plays an important role on metastatic 
activity, being a biomarker of a poor prognosis [17]. Additionally, E-cadherin is a 
transmembrane protein, important to the cell adhesion and cellular migration. Loss of E-
cadherin can cause dedifferentiation and metastatic invasiveness of tumor cells, and its 
presence is viewed as a good biomarker for certain types of cancer (lobular carcinomas) 
[18]. 
Other well-known biomarkers for the recognition of breast cancer cell's behaviour 
are involved in cell cycle deregulation (cyclin D1, p16NK4a and p14ARF) and other 
metastatic factors (vascular endothelial growth factor (VEGF), cyclooxygenase-2 (COX-
2), epidermal growth factor receptor (EGFR) and TGF-α [4].  
 
1.1.1. Breast cancer microenvironment 
Mammary carcinoma, apart from its origins (ductal, lobular or other) is a solid tumor 
with distinct particular phenotypic characteristics. For example, Polyak and collaborators 
have compared the genes corresponding to secreted proteins in ductal carcinoma in situ 
with normal epithelium and concluded that transcription profiles are substantially different. 
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Some genes were found to be upregulated, such as HLA-C I and II, CXCL14 and CXCL12, 
matrix metalloproteinase-2 (MMP2) and TNFAIP6 [6]. MMPs are crucial to the ECM 
remodelling and the upregulation of MMP2 reflects the malignancy of these cells towards 
the invasive and metastatic properties. In the same line of thought, the chemokine CXCL12 
is highly associated with growth, invasion and metastasis of cancer cells (reviewed in [6]). 
CXCL14 is also a chemokine and has the capacity to attract antigen-presenting cells such 
as dendritic cells and NK cells. By this mean, we can evidence the different targets of 
tumor-induced factors: CXCL12 is a pro-tumorigenic and CXCL14 an anti-tumorigenic 
factor. TNFAIP6 is a gene which encodes for a secreted protein involved in extracellular 
matrix stability and migration. It is induced mainly by tumor necrosis factor-α (TNF-α) and 
interleukine-1β (IL-1β) [19]. Cytokines are small glycoproteins greatly involved in 
inflammatory and immunological processes, and on tumor microenvironment they 
markedly influence the cancer cells behaviour [20]. Some of the most studied cancer-
involved cytokines are IL-1β, TNF-α and IL-6, which are present in high levels in the 
tumor microenvironment. These cytokines have potent proliferative properties as 
evidenced  by experiments in  ERα-positive  breast cancer cell lines treated with IL-6 [21].  
 
In spite of their primary protective function, tumor-infiltrating cells such as 
macrophages, monocytes and T lymphocytes (T cells) paradoxically express and secret 
pro-tumorigenic factors. This fact gave a new focus to the researchers, the study of "tumor-
induced cells", such as tumor associated macrophages (TAM) (Figure 1). TAM result from 
the differentiation of monocytes within the tumor microenvironment. In fact, evidences 
showed that the aggressiveness of carcinoma and poor prognosis is directly associated with 
the higher levels of TAM [22]. TAM´s most expressed cytokine is TNF-α, and even if it 
seems highly cytotoxic to the tumor, it was observed that chronic levels of TNF-α in the 
microenvironment actually promotes tumor growth (by inducing expression of MMPs, 
adhesion molecules and reactive oxygen species) [6]. Also T regulatory cells (Treg) have 
influence on tumor growth, as they are able to secrete anti-inflammatory interleukins as IL-
4, IL-10, IL-13 and TGF-β. These cytokines suppress the anti-tumorigenic immunity 
mediated by natural killer (NK) cells and cytotoxic CD8
+ 
T cells and will also modulate 
DC maturation process [23]. 
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Figure 1 - Cancer cells and respective microenvironment, composed by tumor-associated macrophages 
(TAM), T-regulatory cells (Treg), dendritic cells (DC) and myeloid suppressor cells (MSC). The 
secreted cytokines are represented also as well as the respective inhibited/activated targets. Taken from [23]. 
 
2. Immune system and cancer  
As referred above, tumor cells and their microenvironment have particular 
characteristics that perturb the homeostasis of tissues influencing the normal function of 
other cells. To prevent the loss of homeostasis caused by pathogens, inflammatory cells 
and/or tumor cells, the immune system is activated and is responsible for the management 
of those threats.  
The immunogenic properties of cancer cells have been discussed for decades and two 
main theories have been presented: the self-nonself theory which persisted for more than 
60 years and the most recent one, the danger model. The self-nonself theory was suggested 
by Burnet in 1949 and postulates that immature antigen-presenting cells (APCs) act as  
sentinels which are sensitive to genetic foreign entities, such as pathogens (reviewed in 
[24]). However, this theory couldn't explain why immune system is also involved in 
cancer, inflammation, injured cells and also why immune cells didn't attack commensal 
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bacteria that are not a threat to our body. In 1994, Matzinger suggested a renewed model to 
explain it: instead of APC recognize foreign entities, they were able to process danger 
signals (chemokines, cytokines, products from cell degradation, interferon-α (IFNα), IL-
1β, heat-shock proteins (HSPs), among others) from intrinsic cell processes or from 
infected cells [25]. Despite the differences about the origin of the stimulus, the two models 
agreed that the stimulus is processed by non-activated/immature APCs which in turn 
present and prime naïve T lymphocytes triggering the expansion of effector cells, in a 
microenvironment dependent way.  
 
2.1 Cancer immunosurveillance 
APCs, such as dendritic cells and macrophages, are distributed to all tissues in their 
immature state, scanning their microenvironment for any change. When APC experience 
the presence of a tumor antigen, these cells are capable to endocyte the antigen, to process 
it and present it to adaptive immune cells. The processing step is crucial for the correct 
presentation and activation of T cells and it can proceed in 4 different pathways, depending 
on the origin of the antigen: a) endogenous peptides via MHC class I, b) exogenous 
antigens via MHC class II, c) exogenous antigens via MHC class I (cross-presentation)  
and d) lipidic antigens (endogenous/exogenous) via CD1 molecules [26]. In MHC class I 
presentation, endogenous proteins are targeted to proteosomal degradation and products 
proceed to endoplasmic reticulum to bind new synthetized MHC I molecules. This new 
complex (MHCI-antigen) migrates to the cell membrane, where lately they could interact 
with TCR receptor on CD8
+
 T cells. On other hand, the exogenous antigens are endocyted 
and directed to phagolysosomes where antigen peptides are coupled with MHC II 
molecules. These complexes then migrate to the membrane by exocytic vesicles and are 
presented to CD4
+
 T cells. Cross presentation, a unique feature of DCs in vivo, is a process 
where exogenous antigens are presented through MHCI molecules. This process is 
extremely important in anti-tumor immunity given that it leads to CD8
+ 
T cell activation 
into cytotoxic effectors that will destroy tumor cells. Finally, CD1-coupled lipid antigen 
pathway is based on APC-synthesized CD1 molecules which migrate to cytoplasmic 
membrane and bind to the lipid antigen, which can be either exogenous or endogenous. 
CD1-lipidic antigen complex is presented to natural killer T cells (NKT), also potent anti-
tumor effective cells. Once activated, NKT cells produce large amounts of IFN-γ, 
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cytokines such as IL-4 and IL-13 and also the CD40 ligand. CD40 ligand binds to CD40 
receptor in DCs and induces the expression of IL-12, CD80 and CD86, three essential 
molecules in the DCs-mediated antigen presentation to cytotoxic T cells (CTLs) (reviewed 
in [26]).  
The interaction between TCR and CD1/MHC-antigen complexes on the APCs is the 
first and most important signal to initiate T cell priming. However, for effective T cell 
activation, another important second signal is required: the interaction of co-stimulatory 
molecules and its ligands such as CD28/B7 co-stimulatory system (Figure 2). CD28 is a 
co-stimulatory molecule present in the T cell membrane, and upon binding to its ligands 
CD80 and/or CD86, triggers T cells proliferation and differentiation, mainly by inducing 
IL-2 production [27]. The importance of this co-stimulatory signal was demonstrated in 
experiments where CD28
-/-
 T cells were shown to have decreased sensitivity to antigen 
stimulation and a lower IL-2 production [28]. Therefore, the absence of CD28/B7 
interaction during APC antigen presentation rather than induce T cell activation may 
induce anergy (antigen nonresponsivness). This co-stimulatory system is also involved in 
the tumor-induced immunosuppression, as we will describe it later.  
 
 
 
 
 
 
 
 
 
 
Figure 2 - T cell fates according to the different CD80/86 engagements. TCR/MHC-antigen is the first 
signal and is essential to the T cell activation. Even so, the engagement of the co-stimulatory protein 
CD80/86 with the respective receptor, CD28, is necessary. This results in the activation, differentiation and 
proliferation of cytotoxic T cells. However, if T cell possesses the inhibitory receptor CTLA-4 in its 
membrane, CD80/86 binds preferentially to CTLA-4, precluding the stimulatory engagement and leading to 
the cycle arrest in T cell. Taken from [29] 
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2.1.1 Dendritic cells in anti-tumor immunity 
 Among APC, dendritic cells are of most importance in the development of anti-
tumor immunity. DCs are ubiquitously distributed among the organism and play crucial 
roles in driving adaptive immune responses and maintaining immune tolerance to self-
antigens. They function as sentinels, scanning changes in their local microenvironment and 
transferring the information to the cells of the adaptive immune system. The importance of 
DCs on adaptive immune response was first evidenced by Steinman and his team in a 
series of pioneer experiments showing that these cells have unique abilities to prime 
adaptive immune responses. These discoveries lead to a new era of knowledge related to 
the integration between innate and adaptive immunity. Actually, DCs were viewed as a 
heterogeneous family of highly specialized antigen presenting cells that ultimately share 
the same hematopoietic stem cells (HSC) precursor. In bone marrow, HSC give rise to 
common myeloid precursors (CMPs) and common lymphoid precursors (CLPs), which are 
progressively engaged with a particular cell lineage (5). The enormous heterogeneity of 
DC population makes their classification rather complex, and these cells are often 
subdivided based on parameters such as differentiation stage, location in the body, 
migratory properties, expression of surface markers and activation stage. In humans, the 
classification is mainly based on surface markers expression, being DCs classified into two 
major subsets: conventional DCs (cDCs) and plasmocytoid DCs (pDCs). Conventional 
DCs are of myeloid origin being found in tissues and peripheral blood. They can be 
subdivided into CD4
+
CD1a
+
CD11c
hi
CD1c
+
 DCs, the direct precursors of Langerhans cells 
in the epidermis (17) and into CD4
+
CD1a
-
CD11c
low
CD141
+
 DCs, considered the 
precursors of dermal and mucosal DCs. These conventional DCs cells are predominantly 
present in peripheral tissues and play a major role in communicating the in situ danger to 
other cells of the adaptive immune system. (reviewed in [26]) In turn, pDCs have an 
enormous functional plasticity, being able to polarize Th1, Th2 and Treg. However, their 
main role is associated with anti-viral response, by producing high amounts of interferon 
type 1 (IFN-α/β) and by efficiently perform cross presentation of viral antigens to CD8+ T 
lymphocytes (reviewed in [26]).  
In a classical point of view, conventional immature DCs upon a “danger signal” 
suffer a complex process of morphological, phenotypically and functional modifications 
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referred to as maturation. These modifications allows their migration to the T-cell zones in 
the draining lymph nodes where, as activated DC, they present antigens to T lymphocytes 
[30]. The maturation process is a well-coordinated succession of events characterized by 
changes in morphology, loss of endocytic/phagocytic receptors, shift of chemokine 
receptors, resulting in acquisition of migratory capacity, upregulation of the co-stimulatory 
molecules CD40, CD54, CD80, and CD86, alteration of secreted cytokines/chemokines 
(IFN-γ, IL-10, IL-4, IL-13) but also proinflammatory ones (TNF-α, IL-1, IL-6, IL-12, IL-
23) [31]. DC maturation can be triggered by multiple stimuli, including microorganisms or 
microorganism components, proinflammatory cytokines such as IL-1, IL-6, TNF-α and 
signaling molecules such as CD40 ligand (reviewed in [32]). 
 In the context of antitumor immunity, the capture/processing of tumoral antigens by 
DCs and the microenvironment where these events occur will be of upmost importance for 
the effectiveness of the immune response triggered. Tumor antigens may result from the 
phagocytosis and processing of apoptotic cancer cells or may be molecules secreted by 
cancer cells to their environment. These tumor antigens could be tumor-specific antigens 
(mutated or translocated genes such as ras, β-catenin or cdk4, overexpressed proteins like 
p53 and Her2/neu) or tumor-associated antigens (abnormal or overexpressed proteins or 
genes not exclusive from tumors, such as MAGE, BAGE or GAGE) [24].  
2.1.2 Tumor Subversion of DCs immunostimulatory abilities 
Dendritic cells play a central role in priming cytotoxic cells and Th1 lymphocytes; 
therefore one of the main tumors immune escape mechanisms involves the subversion of 
DC immunostimulatory abilities. Although a large spectrum of tumor-mediated 
immunoescape mechanisms have been described (Figure 4) [33], the modulation of the 
different DC subsets is one of the most relevant . Tumor cells are capable to alter the DCs 
differentiation, through the release of granulocyte macrophage colony-stimulating factor, 
GM-CSF (which will act on bone marrow directly), but also through the high levels of 
VEGF, IL-6, macrophage colony-stimulating factor (M-CSF) TGF-β and ROS [32]. 
Additionally, DCs maturation is also modulated by tumor microenvironment, being 
normally impaired. The DC maturation process is crucial to biological functions given that, 
depending on their activation/maturation status, DCs polarize naïve T cells into their 
distinct effector and regulator subsets. The reduced expression of co-stimulatory molecules 
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such as CD80 and CD86 and the down-modulation of either MHC I/II molecules results on 
reduced T cell activation and even in T cell anergy [34]. Moreover, the high level of 
CTLA-4 in tumor microenvironment prevents antigen presentation by blocking CD86-
CD28 interaction [35].  
Another direct consequence of DCs maturation impairment by tumor cells is the 
development of T regulatory cells (Treg). Treg (CD4
+
CD25
+
FOXP3 or CD4
+
CD25
-
FOXP3 T cells) are primarily responsible for promoting tolerance to non-dangerous self-
antigens. This function is vital for the organism survival, as it prevents immune attacks 
towards healthy tissues. However, in the context of cancer, high levels of Treg were found 
in several  tumor microenvironment being related to poor prognosis and tumor progression 
[36]. Several-tumor released cytokines and immunosuppressive molecules such as TGF-β, 
IL-10, IL-6 and VEGF directly contribute to the differentiation of DCs with tolerogenic 
polarizing profiles (reviewed in [26]). The presentation of tumor antigens by these 
tolerogenic DCs will lead to the priming and expansion of tumor antigen specific anergic T 
cells or Tregs. Tregs express CTLA-4, and FasL and secrete soluble factors such as IL-10, 
TGF-β, IL-35, granzyme B, and VEGF that will lyse or inhibit effector T cells (Figure 3), 
and supress immunostimulatory functions of NK and DCs [37]. To clarify the 
differentiation and phenotypic characteristics of tolerogenic DCs, Guerra and collaborators 
have stimulated monocyte-derived DCs with IL-10, IL-6 and TGF-β (simulating the tumor 
microenvironment) and observed that the resulted DCs had increased expression of IL-6 
and IL-10, and lower secretion of proinflammatory cytokines such as IL-12 and IL-23 [38].  
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Figure 3 - Mechanisms by which Treg cells impair the function of DCs in the immunosuppressive 
tumor microenvironment. a) TGF-β and immunosuppressive ILs directly inhibit the cytotoxic action of 
activated T cells; b) granzyme A or B pass through perforine-mediated pores in T cell resulting in cytolisis of 
effector T cell; c) CD25 is a competitive receptor for the IL-12, necessary to the T cell activation. CD39 and 
CD73-generated adenosine inhibits T cells and direct transfer of cyclic AMP (cAMP) to T cells through gap 
junctions result in the suppression of T cells; d) T reg induced indoleamine 2,3-dioxygenase (IDO) that will 
act on effector T cells and induce the expression of pro-apoptotic molecules. Taken from [39] 
 
Additionally, some studies showed that DCs from tumor environment had reduced 
ability to activate T cells not only because these cells expressed low levels of co-
stimulatory molecules, but also because levels of viable DCs are lower than in healthy 
patients (reviewed in [40]). Supporting this fact, Lopez and co-workers found higher levels 
of apoptotic blood DCs on breast cancer patients compared to controls. They conclude that 
tumor-induced apoptosis resulted from downregulation of Bcl-2, an anti-apoptotic protein, 
adding another immunosuppresive mechanism to the subject [41].  
Recent studies have described a new mechanism by which tumor cells may impair 
dendritic cell functions: cancer cells under endoplasmic reticulum stress release to their 
microenvironment several factors that transmit ER stress to neighbour cells including 
immune cells such as DCs. These ER stressed-DCs were shown to have deregulated 
maturation capacities and to possess limited stimulatory abilities [42,43]. This phenomena 
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was named transmissible ER stress (TERS) and is the main focus of the present work, 
being discussed in detail in the last chapter, Paradoxical role of ER stress in cancer. 
 
Figure 4 - Schematic view of the principal tumor-induced tolerance mechanisms. Despite of the anti-
tumorigenic immune cells function, tumor cells are capable to modulate those mechanisms in benefit to the 
tumor survival and progression; the induction of apoptosis is the most well-known mechanism on cancer 
patients, which presented high levels of apoptotic immune cells on blood; the direct polarization of T cells in 
Treg, a suppressive phenotype; the inhibition of DC differentiation is mediated by the myeloid-derived 
suppressive cells, induced by the tumor-mediated IL-6; the direct influence on T cells, either by expressing 
CTLA-4, which blocks the co-stimulatory signal necessary to the T cell activation, but also by disrupting the 
TCR with the high levels of peroxinitrite. Some of these mechanisms are mediated by tumor-derived 
exosomes; however most of them are not clarified yet. 
 
3. ER stress 
Endoplasmic reticulum (ER) is a cellular constituent crucial to posttranslational 
protein modifications as it grants the proper protein folding. The effectiveness of protein-
folding reactions depends on suitable environmental, genetic, and metabolic conditions and 
unbalances of these processes present a threat to cell viability and functionality. Conditions 
such as hypoxia, Ca
2+
 depletion, alteration on translational enzymes, glucose and/or amino 
acids deprivation, low pH, and changes on cell redox status can perturb ER homeostasis 
resulting in accumulation of unfolded proteins [44]. When ER stress occurs, healthy cells 
are able to detoxify misfolded proteins by activating an intrinsic response, known as 
unfolded protein response (UPR). UPR has two main steps: the first one evolves the 
maintenance of ER homeostasis, by slowing down translational process and also by 
chaperoning misfolded proteins (by GRP90, GRP78 or GRP94 upregulation) or even 
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ubiquitinated and degraded, by a process usually named by ER-associated protein 
degradation (ERAD) [45]. The ERAD process involves the expression of molecular 
chaperones that recognize and target misfolded proteins to cytoplasm where they are 
ubiquitinated and go through proteasomal degradation. Autophagy is also a mechanism 
that ER stressed cells make use to clear the non-resolved protein accumulation. The second 
step is the induction of apoptosis, when UPR recovery mechanisms aren't enough to re-
establish the ER homeostasis and noxious stimuli are prolonged [45].  
 
3.1 The Unfolded protein response 
Proper adjustment to misfolded proteins requires modifications at multiple levels and 
cells developed complex mechanisms to avoid their accumulation. UPR is characterized by 
3 parallel branches: inositol-requiring kinase 1 (IRE1), protein kinase-like ER kinase 
(PERK) and activating transcription factor (ATF6) pathways (Figure 5). The activation of 
UPR kinases will result on 1) slowdown the de novo entry of proteins in ER lumen 2) 
unfolded proteins repair to their functional form and/or 3) elimination of remaining 
abnormal proteins [46]. Each of these UPR-sensors is dependent of their 
binding/dissociation to the chaperone protein GRP78. When the protein synthesis rate is 
normal and efficient, the level of proteins on the ER lumen is low and the chaperone 
GRP78 is bound to IRE1, PERK and ATF6. However if ER homeostasis is unbalanced, 
efficient folding of proteins is compromised and misfolded proteins start to accumulate at 
ER lumen. In order to prevent formation of highly cytotoxic protein aggregates the 
chaperone GRP78 binds preferentially to those proteins, dissociating from the UPR-related 
kinases [46]. This dissociation triggers the phosphorylation and the activation of UPR 
pathways. 
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Figure 5 - Schematic view of the three branches of UPR in ER stressed cells. The activation of UPR-
sensors is mediated by GRP78 association, and upon higher levels of misfolded proteins, GRP78 dissociates 
from PERK, ATF6 and IRE1. eIF2α phosphorylation by activated PERK selectively increases the translation 
of ATF4, an important transcription factor that upregulates specific genes such as chaperones and CHOP. 
ATF6 is cleaved in Golgi apparatus and the released cytosolic domain migrates to the nucleus where it 
activates the transcription of proteins involved in ERAD, refolding processes (as PDI) and also apoptosis 
(CHOP). IRE1 cleaves XBP1 mRNA and releases the activating transcription factors XBP1, also responsible 
for ER chaperones upregulation. Taken from [47]. 
 
3.1.1 IRE1α branch 
IRE1α is a serine/threonine protein kinase with endoribonuclease activity. Its 
dissociation from GRP78 allows IRE1α to homodimerize and auto-transphosphorylate, 
resulting in activation of its endonuclease activity. From that stage, two signalling cascades 
can be activated 1) X-box binding protein 1 (XBP1) splicing that attenuates de novo 
protein entrance in stressed ER and 2) JNK-induced apoptosis. Spliced XBP1 translocates 
to the nucleus and initiate the transcription of ER-stress response elements (ESRE), 
essentially chaperones that promote the correct protein folding in ER. However, the most 
prominent transcriptional XBP1-targets are genes involved in ERAD process, chaperones 
molecules designed to conduct misfolded proteins to proteasomal degradation. The IRE1 
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can also interact and bind to tumor necrosis factor receptor-associated factor 2 (TRAF2) 
which activates apoptosis signal-regulating kinase 1, which in turn, activates JNK. In 
unstressed cells, TRAF is associated with inactive procaspase-12; however, under ER 
stress, TRAF2 dissociates from procaspase-12, releasing it into the cytosol. Procaspase-12 
homodimerizes and suffer a cleavage that results in caspase-12 initiating an apoptotic 
cascade that culminates  in cell death [48].  
 
3.1.2 PERK branch 
One of the main consequences of unfolded protein accumulation at ER is a rapid 
mRNA translation attenuation in order to prevent the influx of newly synthesized proteins. 
This translation arrest is mainly due to PERK-mediated phosphorylation of the eukaryotic 
translation initiation factor 2 at its α-subunit (eIF2α) [49].  
PERK is a transmembrane protein kinase that following dissociation from GRP78, 
dimerizes and transphosphorylates, resulting on the active form. The kinase property will 
result on the phosphorylation of eIF2α. The phosphorylation of eIF2α subunit decreases 
the formation of translation complex, resulting in de novo protein translation attenuation. 
Although PERK-mediated phosphorylation of eIF2α inhibits the translational processes in 
general, it selectively activates the translation of one essential transcription factor of the 
UPR: the activating transcription factor 4 (ATF4). ATF4 induces the expression of stress 
related-genes, genes involved in amino acid metabolism, antioxidant response and 
apoptosis such as the DNA damage 34 (GADD34) and the growth arrest and DNA 
damage-inducible protein (GADD153)/CHOP [45]. In turn, CHOP suppresses the 
transcription of the anti-apoptotic Bcl-2 family proteins, such as Bcl-2, Bcl-xL and Bcl-w. 
Other two CHOP targets are the activation of GADD34 which dephosphorylates eIF2α and 
inhibits PERK UPR-branch signalling and the activation of ER oxidoreductase (ERO1α) 
that develops an oxidizing environment in the ER, leading the cell towards death [50]. A 
growing body of data suggests that PERK branch of UPR, plays crucial roles in the 
protection of cells from oxidative stress (reviewed in [51]). Consistent with this notion, 
PERK
-/-
 mouse embryonic fibroblasts showed to accumulate reactive oxygen species and 
to had a significant reduced survival to hypoxia stimulus when compared to wild-type 
fibroblasts [52]. 
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3.1.3 ATF6 branch 
Activating Transcription factor 6 (ATF6) is also involved on the UPR activation 
mechanisms. Upon ER stress, GRP78 releases from ATF6 to bind misfolded proteins on 
the ER lumen, allowing ATF6 to migrate towards Golgi apparatus for proteolytic cleavage 
by site-1 (S1P) and site-2 (S2P) proteases. S1P and S2P releases the cytosolic fragment of 
ATF6 which translocates into nucleus in order to activate the transcription of specific 
group genes: CHOP, ER chaperones and ERAD components [45]. The involvement of 
ATF6 branch in UPR-triggered apoptosis is not consensual; however, its role in ER stress 
recovery is well established, as it highly induces the expression of GRP78 and HSP90 
chaperones [53]. 
 
3.2 Refolding, ERAD and autophagy mechanisms 
In parallel to UPR, ERAD process is responsible for detoxifying stressed cells from 
misfolded proteins accumulated in ER lumen and, as UPR, re-establish the function of ER. 
This degradative process is characterized by 4 steps: 1) recognition, 2) retrotranslocation, 
3) ubiquitination and 4) degradation. Despite the different goals of each step, they are all 
supported by chaperone proteins, namely GRP78, GRP94, protein disulphide isomerase 
(PDI), calnexin (CNX) and calreticulin (CRT) (reviewed in [54]). GRP78 and GRP94, as 
mentioned in the UPR system review, bind to the misfolded proteins with higher affinity 
compared to the UPR-sensors. In this way, GRP78 and GRP94 not only allow the UPR-
sensors activation but also prevent the formation of misfolded proteins aggregates. GRP78 
is one of the most studied proteins among ER stress and is well recognized as a ER stress 
biomarker (57–60). Moreover, among certain ER stress-related diseases, GRP78 levels can 
be used as diagnostic or prognostic marker. For example, in a study with 219 prostate 
cancer patients, it was observed an association between high levels of GRP78 and resistant 
tumor cells, as well as an enhanced risk of tumor recurrence and decreased patient survival 
[58]. This overexpression was also observed in mammary and virus-related hepatocellular 
carcinoma [56,59]. In rheumatoid arthritis salivary proteome, Giusti and collaborators 
found that GRP78 levels were increased about 7-fold in patients when compared  to 
healthy individuals [60].  
ERAD system provides an effective cleaning of misfolded proteins accumulated in 
the ER, either because of mutation, incorrect translation or even inability to form the 
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correct protein complexes. Thus, de novo translated proteins in ER are glycosylated in 
order to control and manage the folding maturation of the protein. This glycosylation is 
supported by an enriched-mannose N-glycan with 3 final residues of glucose. Two of those 
glucose residues are de-glycosylated by glycosidase I and II, resulting in a new 
glycoprotein recognized by the CNX/CRT system. CNX/CRT associates with PDI to 
promote the oxidizing environment needed to the correct protein folding. This system is 
highly effective if the misfolded error has its origin from posttranslational stages. 
However, if this system is badly-succeeded, α-mannosidases and ER degradation enhancer 
mannosidase (EDEM) cleaves the terminal mannose residues from the glycoprotein 
allowing the recognition by other two ER resident enzymes: osteosarcoma 9 and XTP3-
transactivated gene, both containing the mannose-6-phosphate receptor-like domain, 
necessary for the mannose residues recognition. As the proteasome machinery is in the 
cytosol, those misfolded recognized proteins need to translocate from ER lumen to the 
cytosol. The mechanisms governing this second ERAD step (retrotranslocation) are still 
not completely fully disclosed and their comprehension is an extremely challenging 
scientific field. Once in the cytosol, misfolded proteins are ubiquitinated by the E1-E2-E3 
ubiquitin system (activation-, conjugation- and ligation-enzymes, respectively) and enter 
into the proteasome, in order to be degraded (reviewed in [54]).  
Finally, autophagy is another process by which stressed cells are able to clear the 
high levels of misfolded proteins. Despite the established relation between ER stress and 
autophagosome formation, the molecular mechanism behind these two events is still under 
discussion. In an exploratory study to understand which of ER stress-sensor could be 
involved in the formation of autophagossomes, the process was shown to be dependent on 
the IRE1-JNK pathway, as IRE1-deficient cell were unable to form autophagosomes [61]. 
However, in a Huntington in vitro disease model (polyglutamine aggregation) Kouroku 
and his team observed that autophagosomes formation was rather dependent of PERK/eIF2 
pathway [62].  
These cytoprotective mechanisms (UPR, refolding, ERAD and autophagy) should be 
able to recover the ER and cell homeostasis. However, in pathologic/inflammatory 
conditions, the persistent ER stress can switch the cytoprotective functions of UPR and 
autophagy into cell death promoting mechanisms [47].  
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3.3 ER stress-induced apoptosis 
Apoptosis, or programmed cell death, is the ultimately consequence when cells were 
not able to restore ER homeostasis. In those conditions, IRE1 and PERK activate two 
parallel pathways: JNK and CHOP apoptotic pathways, respectively [47]. The prolonged 
ER stress state is reflected by the overexpression of IRE1 which is intimately related to the 
increased levels of CHOP [63]. CHOP blocks anti-apoptotic molecules expression such as 
Bcl-2 family proteins and upregulates GADD34 and TRB3 [64]. In parallel, IRE1 
associates with TRAF2 activating ASK1 that in turn triggers JNK-dependent apoptotic 
processes: the phosphorylation of BH3-only members of Bcl-2, such as Bim (a pro-
apoptotic molecule), induces its migration from the cytoskeleton to the ER membrane and 
phosphorylation of Bcl-2 protein leads to its suppression [47]. This 2 different action of 
ASK1 phosphorylation converges to the cell apoptotic fate. Bcl-2 family proteins Bax and 
Bak are also associated with ER-stress apoptosis. When "free" Bax and Bak levels increase 
in cytosol, they migrate into the mitochondrial outer membrane, oligomerize and create 
mitochondrial pores, allowing cytochrome c to leak over the cytosol [65]. Once released, 
cytochrome c activates the caspase cascade, culminating in cell apoptosis. Bak and Bax 
were first linked to ER stress-induced apoptosis when Wei and colleagues induce apoptosis 
(Fas-independent) in  Bak
-/-
 and Bax
-/-
 mice  and observed a higher survival rate, compared 
to the other genotypes [66].  
As mentioned before, one of the stimuli that can trigger ER stress is the alteration of 
Ca
2+
 levels. In this case, an UPR-independent pathway is additionally activated: activated 
calpain cleaves procaspase-12, releasing caspase-12 to migrate towards the cytosol and 
activate the caspase cascade [66].  
 
3.4 ER stress in human diseases 
In recent years, interest in ER stress mechanisms greatly increased due to its 
association with various diseases and pathological states. The most well-known are 
neurodegenerative pathologies such as Alzheimer, Huntington, Parkinson and Prion 
diseases. These diseases are characterized by the accumulation of misfolded proteins and 
an impaired protein degradation system, affecting different cell signalling pathways which 
can result on suppression of neuronal communication or even cell death. In Alzheimer 
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disease, IRE1 was found to be inhibited by mutant protein S from secretase complex, 
leading to an impaired UPR response (reviewed in [67]). However some studies showed 
increased levels of PERK in brain of Alzheimer's patients, indicating that ER stress-
apoptotic pathway could be activated (reviewed in [67]). In Parkinson's disease the  levels 
of UPR chaperones and phosphorylated IRE1 and PERK, as well as CHOP, clarified  the 
involvement  of the UPR in this pathology [68]. In turn, Huntington disease present a 
particular feature caused by a mutation in chromosome 4, leading to expanded 
polyglutamine repeats in various proteins. ER stress is triggered by a hampering and 
impairment of proteasomal system, leading to an accumulation of these proteins in ER 
lumen. Also high levels of CHOP and GRP78 were found in Huntington cells and  ASK1 
(from IRE1-pathway) was  shown to be essential to polyglutamine-induced ER-mediated 
cell death [69]. Additionally, ER stress is also associated with proinflammatory chronic 
processes, such as type 2 diabetes, atherosclerosis, intestinal bowel disease and cancer. 
Nevertheless ER stress-induced inflammation has not a linear effect on all cells and tissues, 
and the final output will depend on the targeted cell and its microenvironment. While in the 
majority of the referred inflammatory pathologies ER stress is a deleterious process 
culminating in cell death, in cancer it can either act as a pro-survival mechanism or be 
involved in tumor cell apoptosis and immunogenic signals (reviewed in [70]). 
 
3.5 Paradoxical role of ER stress in cancer 
Tumor cells are surrounded by a very particular microenvironment characterized by 
adverse conditions to cell survival, such as hypoxia, nutrient deprivation, low pH and high 
levels of ROS. In such extreme conditions, protein synthesis is highly affected, either 
because of the insufficient glycosylation, the unfavourable conditions to the establishment 
of disulphide bonds, or the proteins transformation by ROS interaction. As a result, the cell 
enter in a prolonged ER stress and UPR mechanism is not sufficient to restore homeostasis  
[71]. Several studies reported higher levels of ER stress in cancer cells, comparing to the 
healthy tissues, as for example in colorectal, lung and mammary carcinoma (48-50). In a 
study with colon cancer as a model, 98% of biopsies from cancer patients stained positive 
to GRP78 whereas only 48% of samples from healthy tissues stain positive [55]. 
Moreover, cancer lung cells have also been shown to present higher levels of ER stress 
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(about 3-fold) when compared to healthy cells [57]. These results, among others, 
contributed to the understanding of the close relation between tumor cells and high and 
chronic levels of ER stress. Despite of the clear evidences pointing to elevated ER stress in 
solid tumors, its outcome in cell death or survival remains inconclusive. As described 
before, prolonged ER stress leads to the activation of pro- apoptotic pathways of the UPR. 
Therefore, its most logic role in cancer would be as an anti-tumoral process. However, 
increasing evidences point that ER stress may be central in the modulation of several pro-
tumoral mechanisms [71]. UPR activation was shown to be essential to the tumor survival 
under hypoxic conditions [51,72,73]. The higher apoptosis rate of XBP1-deficient cells 
under hypoxic conditions indicated that XBP1-deficient cells are more sensitive than the 
wild-type ones [72]. Also PERK-deficient tumors were more sensitive to hypoxia as they 
grew less than the PERK-positive tumors [73]. These studies converged to the hypothesis 
that UPR activation is fundamental to cell survival under hypoxic conditions; however, the 
mechanisms behind those associations aren't yet clear.  
In addition to those tumor cell-intrinsic mechanisms, ER stress is also implicated in 
extracellular actions, all associated with pro-survival events of the tumor. It is well 
established that under hypoxic conditions tumor cells secrete VEGF though a HIF-1α-
dependent mechanism in order to promote vascularisation. However, some studies showed 
that the upregulation of VEGF was HIF-1 independent in some cellular models. On those 
cases, ER stress plays an important role as the UPR mediator IRE1 is the key factor on the 
upregulation of VEGF [74]. Also PERK has some influence in angiogenesis regulation, as 
showed in experiments where PERK
-/-
 mice developed smaller tumors than PERK-positive 
mice. Moreover, the formation of microvessels was analysed in vivo and the authors 
observed about 16-fold more vessels counted by section of tissue on PERK
+/+
 mice, 
concluding that PERK activation is important to the vascularization of the tumor [75]. 
As an additional mechanism that links UPR to tumor survival, chaperones such as 
GRP78, were shown to protect tumor cell against cytotoxic T cells mediated lysis [76]. 
This finding was demonstrated in an elegant experiment where GRP78 silenced cells were 
injected in mice with fibrosarcoma, being the progression and incidence of tumors 
monitored along the time. Mice with suppressed GRP78 showed a lower incidence and 
progression of tumors, and the regression of the initially formed tumors pointed to some 
anti-tumoral attack by CTL [76].  
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Inflammation is also a characteristic of tumor microenvironment and is influenced by 
ER stress in tumor and surrounding cells. Inflammatory mediators present in tumor 
microenvironment induce tumor-promoting cytokines, such as IL-11, IL-1β, IL-6, IL-23 
and TNF that can act as autocrine and paracrine survival, growth and metastatic factors. 
This is view as a "private" signalling between tumor cells, as they upregulate, for example 
the IL6 receptor, exerting its proinflammatory and anti-apoptotic action more prominently 
on cancer cells (reviewed in [70]). High levels of TNF-α cause ROS accumulation, which 
in turn lead to the activation of UPR signalling (to rescue the oxidized proteins). 
Production of ROS and protein folding are closely linked events. Uncontrolled production 
of ROS can directly or indirectly affect ER homeostasis and perturbations in protein 
folding can cause alterations in cellular redox status increasing the generation of 
mitochondrial ROS. High levels of cytokines, especially TNF-α, in addition to ROS 
induction, are also responsible for the direct activation of UPR-sensors, by the NF-kB 
signalling pathway (reviewed in [70]). IRE1α associates with TRAF2 and together mediate 
IkB phosphorylation resulting in NF-kB activation. Also ATF6/AKT and JNK have been 
associated to NF-kB activation and consequent inflammatory gene upregulation (reviewed 
in [71]). Therefore, tumor proinflammatory microenvironment induces ER stress which in 
turn enhances inflammatory mediators expression, among tumor and immune cells. ER 
stress/inflammation/tumor cells association suggested that tumor cells under ER stress 
could transmit stressing signals to neighbour cells modulating their activity and functions.  
Recently a new body of data highlight the role of tumor UPR as a critical modulator 
of antitumor immunity through transmissible extrinsic effects on infiltrating immune cells, 
a mechanism denominated Transmissible Endoplasmic Reticulum Stress (TERS) (Table 2). 
Macrophages cultured in conditioned medium from ER-stressed tumor cells were shown to 
strongly develop ER stress [77]. In posterior studies the same group evidenced that DC 
cultured in the same ER-stressed tumor cells conditioned media present clear evidences of 
ER stress with high levels of GRP78 and arginase 1 expression [42]. ER stress in DCs 
impairs the translation and posttranslational mechanisms that will result in the incapacity to 
properly fold MHC I and CD80, CD86, CD40 and other co-stimulatory molecules, 
essential for antigen presentation. In fact, in vivo experiments showed that TERS-imprinted 
DCs were inefficient in priming CD8
+
 T lymphocytes [42].  
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Apart from the impaired protein translation, the activation of UPR pathways in DC 
will also lead to a pro-tumorigenic phenotype, mainly through secretion of cytokines and 
growth factors. ER stress and Toll-like receptor stimulation induced, in myeloid DCs, an 
upregulation on p19 subunit of IL23, as well as an increased expression of IL-23 and 
several chemokines [42,43]. Additionally, ER-primed DCs overexpress 
immunosuppressive molecules such as B7 homolog 1 (B7-H1) [42] that are well known to 
inhibit CD8
+
 T cell proliferation and to cause suppression of antigen cross-presentation 
[78]. In fact, experiments in which tumor-imprinted ER stress DCs were cultured with 
CD8
+
 T cells resulted in a marked alteration of their transcriptional profile: upregulation of  
IL10, TNFα and FOXP3, as well as the downregulation of co-stimulatory molecule, CD28 
[42]. Such profile is comparable to Treg phenotypic profile, and indicates that ER stressed 
primed DCs have the capacity to polarize CD8
+
 T cells towards a more regulatory profile 
(Table 2). 
Overall, these data suggest that tumor secretome may be the key behind the tumor 
cells "Transmissible" ER stress (TERS). However, the precise nature of stimuli that trigger 
ER stress in tumor cells and the vehicle by which ER stress is transmitted is still 
unidentified. In the present work we hypothesized that this transmission could be 
accomplished by tumor-derived exosomes. Exosomes are involved in multiple tumor 
extrinsic signalling processes, namely in the immunosuppression, in the extracellular 
matrix, vascular and stromal cells transformation and also in drug interference (for more 
details see [79]). Recently, new data have highlighted the important role of tumor-derived 
exosomes on the modulation of surrounding cells in order to promote and benefit the 
tumorigenesis process. Melo and her colleagues have reported and described the capacity 
of breast cancer-derived exosomes to reprogram non-malignant cells into tumorigenic 
cells, driven by exosomal microRNAs [80]. The study of exosomes as a possible vehicle to 
communication, re-programmation and transport of several factors is still on the beginning 
however seems very promising. 
 
 
 
 
 24 
Table 2 - Incident studies reporting an association between tumor-induced ER stress and changes in 
protein expression profile. 
Target 
cell 
Cell-derived 
CM 
ER stress 
inducer 
Results Ref. 
Mo Prostate 
cancer 
Lewis lung 
carcinoma and 
metastic 
melanoma 
Thapsigargin 
 
Thapsigargin/ 
lacking of glucose 
Upregulation of GRP78, GADD34 and 
CHOP; overexpression of IL-6, IL-23p19 
[77] 
BMDM Prostate 
cancer 
Thapsigargin The same results as the previous the ones 
with Mo; overexpression of TNF-α, MIP-1α 
and MIP-1β 
[77] 
BMDC Lewis lung 
carcinoma, 
metastic 
melanoma and 
prostate 
cancer 
Thapsigargin Upregulation of GRP78 and downstream of 
XBP1 and CHOP; Upregulation the 
transcription of IL6, IL23p19 and TNFα; 
Oversecretion of IL-6, IL-23, TNF-α, TGF-
β, MIP-1α, MIP-1β and MCP-1. 
Overexpression of arginase 1 
Overexpression of PD-L1  
Decreased levels of CD28, increased levels 
of Lag3, IL10 and TNFα and FOXP3 on T 
cells 
[42] 
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Aim of the study 
 Tumor microenvironment provides particular conditions that are prone to favour 
tumor cells survival and proliferation even under attack by immune cells. A wide spectrum 
of immunoescape mechanisms have been reported and studied for years, however the role 
of tumor-induced ER stress in immune cells is not fully disclosed. Recent studies proposed 
that tumor stressed cells were able to transmit ER stress to surrounding cells including 
DCs, subverting their maturation process and their immunostimulatory abilities.  In fact 
until now, only two studies reported tumor-induced ER stress in myeloid cells, remaining 
the mechanism by which such ER stress is transmitted completely unknown. 
 Thus, the main objectives of this work are: 
1. To evaluate the capacity of tumor microenvironment stressors, such as hypoxia, 
acidic medium and glucose deprivation to induce ER stress in a breast cancer 
luminal A cell line (T-47D cells)  
2. To evaluate the capacity of conditioned medium from tumor cells to induce ER 
stress in myeloid dendritic cells. 
3. To assess the effects of this transmitted ER stress on DCs phenotype and functions 
4. To study the factors/mechanisms responsible for the transmission of ER stress by 
the tumor cells  
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Methods and materials 
  
Breast cancer 
cells (T-47D) 
Induction of ER stress (tunicamycin, glucose deprivation, acidosis, and hypoxia) 
WB (ATF4, 
GRP78, 
CHOP) 
qRT-PCR (ATF4, 
CHOP, GRP78, IL8, 
IL6, VEGFA, VEGFB, 
IL10) 
Recover the CM CM + THP-1 
culture cells 
Exosomes isolation 
(Exo-quick kit) 
Exosomes + THP-
1 culture cells 
THP-1 (TERS and 
functional 
analysis) 
WB 
(ATF4, 
CHOP) 
qRT-PCR (ATF4, 
CHOP, CD86, IL6, 
IL8,, IL1β) 
Exosome content 
characterization  
(LC-MS/MS) 
Figure 6 – Schematic representation of the general methodology approaches conducted in this 
project.  
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1. Cell Culture 
T-47D human breast cancer adherent cells (ATCC HTB133, American Type Culture 
Collection, Manassas, VA) were routinely seeded and maintained in T-75 culture flasks in 
Roswell Park Memorial Institute (RPMI) 1640 medium (Sigma Chemical Co., St. Louis, 
MO, USA) supplemented with 10% (v/v) of heat-inactivated fetal bovine serum (FBS) 
(Sigma Chemical Co., St. Louis, MO, USA), 25 mM glucose, 10 mM HEPES, 100 µg/mL 
streptomycin, 1mM sodium pyruvate and 100 U/mL penicillin (designated hereinafter by 
RPMI 10% FBS); Cell were incubated at 37ºC in humid atmosphere with 5% carbon 
dioxide. Passaging was performed when cells reached confluence level about 80%. For 
different experimental approaches, cells were incubated and treated as described above: 
1) Induction of ER stress in breast cancer cells: T-47D cells were plated in 
100mm plastic dishes and/or 6-well-plates at the respective seeding density and 
incubated with the different medium composition described in Table 3. All the 
different growth conditions were maintained for 4h and 24h before RNA/protein 
extraction; cells were grown until 60% confluence.  
Table 3 – Description of the cell culture features and treatments associated to the induction of ER 
stress in T-47D cells  
T-47D Stimuli 
Seeding density 
Growth medium composition 
WB qRT-PCR 
Tunicamycin 
1.0 x 106 cell 
 
(0.3 x 106 for 
 T-47D cell 
metabolism 
assay) 
0.30 x 10
6 
cell 
RPMI 10% FBS + tunicamycin (Sigma) 
10 µg/mL 
Glucose deprivation RPMI 10% FBS without glucose 
Lactic Acidosis RPMI 10% FBS + lactic acid (pH=6) 
Glucose deprivation + lactic 
acidosis 
RPMI 10% FBS without glucose + lactic 
acid (pH=6) 
Phenantroline 
RPMI 10% FBS + phenantroline 
(Sigma) 15µmol/mL 
Cobalt chloride (CoCl2) 
RPMI 10% FBS + CoCl2 (Sigma 
Aldrich)  
Hydrochloric acid (HCl) RPMI 10% FBS + HCl (Sigma) (pH=6) 
Glucose deprivation + HCl 
RPMI 10% FBS without glucose + HCl 
(pH=6) 
 
2) Conditioned medium (CM) production: T-47D-derived CM was obtained by 
culturing T-47D cells in T-75 flasks until 60% confluence. Then ER stress was 
induced either by tunicamycin or glucose deprivation (Table 4). Tunicamycin was 
washed after 4h of incubation and T-47D cells were supplemented with fresh 
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medium and grown for 24h. After 24h CM was recovered and centrifuged at 5000 g 
for 10 min to remove cell debris. 
3) Exosomes production: T-47D-derived exosomes were obtained by culturing T-47D 
cells in the same conditions as CM production (point 2) except that RPMI medium 
was supplemented with 10% exosome-free FBS (Table 4); 
Table 4 - Description of the cell culture features and treatments associated to the exosome-producing 
T-47D cells. 
T-47D Stimuli Seeding density Growth medium composition 
Tunicamycin 
2.1 x 10
6 
cell 
RPMI 10% FBS + tunicamycin 10 µg/mL 
Glucose deprivation RPMI 10% FBS without glucose 
 
4) T-47D ER stress and glucose metabolism experiment: T-47D cells were grown in 
60 mm plates and/or 6-well-plates (for protein and RNA extraction respectively) 
for 24h on the respective treatment (tunicamycin, glucose deprivation, glucose 
deprivation + lactate, lactate, glucose deprivation + hydrochloride acid (HCl) and 
hydrochloride acid) as described in Table 3. 
5) THP-1 culture and incubation with CM and/or T-47D-isolated exosomes: THP-1 
suspension cells were routinely maintained with RPMI 10% FBS. For TERS 
assessment, THP-1 cells were left to grow for 48h in 6-well-plate (with initial 
seeding density of 0.8 x 10
6
 cell/well) and incubated with 3 mL of CM and/or T-
47D-isolated exosomes. For maturation status and cytokine analysis THP-1 cells 
were treated with 1µg/mL of lipopolysaccharide one hour prior to exosomes 
incubation. 
2. Evaluation of cell viability 
Resazurin reagent was used to assess cell viability, using different concentrations of 
tunicamycin. Cells were seeded in 96-well-plate and exposed to different tunicamycin 
concentrations (1, 2, 5, 10 µg/mL) for 24h. Occurred that period, resazurin (Sigma 
Chemical Co. St. Louis, MO, USA) was added for 4h with a final concentration of 50 µM, 
and absorbance was read at 570 and 600 nm in Multiskan Go spectrophotometer (Thermo 
Fisher Scientific, Waltham, MA, USA). 
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3. Protein extraction and quantification 
To obtain whole cell lysates, T-47D and THP-1 cells were washed in ice-cold PBS 
and harvested in RIPA lysis buffer (50 mM Tris–HCl (pH 8.0), 1% Nonidet P-40, 150 mM 
NaCl, 0.5% sodium deoxycholate, 0.1% (w/v) SDS, 2 mM EDTA) freshly supplemented 
with protease and phosphatase inhibitor cocktails (Roche, Mannheim, Germany) and 1 mM 
DTT. The insoluble cell debris was then removed by centrifugation at 14000 g at 4 
◦
C for 
10 min. Supernatant was collected and used as total cell lysate. Protein concentration was 
determined using the bicinchoninic acid method (Sigma Chemical Co, St. Louis, MO, 
USA) [81]. To obtain exosomal protein quantification, purified eluate-containing 
exosomes was harvested in RIPA lysis buffer in non-reducing conditions (50 mM Tris–
HCl (pH 8.0), 1% Nonidet P-40, 150 mM NaCl, 0.5% sodium deoxycholate, 0.1% (w/v) 
SDS, 2 mM EDTA), freshly supplemented with protease and phosphatase inhibitor 
cocktails (Roche, Mannheim, Germany). The insoluble debris was then removed by 
centrifugation at 4ºC at 14000 g for 10 min. Supernatant was collected and used as total 
exosome lysate. Protein concentration was determined using the bicinchoninic acid method 
(Sigma Chemical Co, St. Louis, MO, USA) [81]. 
4. Western-Blot 
For CHOP, ATF4, GRP78, CD81 and CD63 detection it was added denaturing buffer 
(0.125 mM Tris pH 6.8; 2% (w/v) SDS; 100 mM DTT; 10% (v/v) glycerol and 
bromophenol blue) to each supernatant (1:1) and the samples were boiled for 5 min at 
95ºC. Then 20-30 µg of total lysate was applied to a SDS-PAGE 12% (v/v) 
bisacrilamide/acrylamide gel. Proteins were separated by eletrophoresis (140 V, 90 
minutes) and transferred to polyvinylidene difluoride (PVDF) membranes (Milipore, 
Bedfore, MA, USA). Non-specific binding was blocked with 5% (w/v) of skimmed milk in 
TBS-T (100 mM Tris pH 8.0, 1.5 mM NaCl and 0.1% Tween-20) during 1h at room 
temperature and under soft and continuous stirring. To detection of ER stress markers, 
membranes were incubated overnight with monoclonal antibody rabbit anti-ATF4 (Cell 
signalling Technology), mouse -CHOP (Cell Signalling Technology), rat -GRP78 
(Biolegend, San Diego, CA, USA), mouse/rat –CD81 (Biolegend, San Diego, CA, USA) 
and mouse –CD63 (Biolegend, San Diego, CA, USA) diluted by 1:1000 factor each one; 
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The membranes were then washed three times to remove unbound antibodies, for 10 min 
each, in TBS-T, followed by a secondary antibody incubation anti-rat, anti-mouse or anti-
rabbit associated to the alkaline phosphatase, for 1h room temperature. Finally membranes 
were exposed to ECF (GE Healthcare, Chalfont St. Giles, UK) reagent and 
immunocomplexes were detected by scanning the membrane for blue excited fluorescence 
on the Typhon (GE Healthcare, Chalfont St. Giles, UK) and analysed using the software 
TL120 v2009 (TotalLab Ltd, Durham, USA). As loading control, membranes were 
stripped and incubated with anti-tubulin antibody. 
5. RNA extraction 
 For RNA extraction, T-47D and THP-1 cells were cultured as indicated previously 
in Table 3 for 4 or 24h. Total RNA was isolated from cells adding 1 mL of NZYol reagent 
(NZYTech, Lisbon, Portugal) to each well. After pipetting several times the cell lysate, 
200 µL of chloroform was added and the sample was shacked vigorously, incubated for 2 
min at room temperature and centrifuged for 12,000 g for 15 min at 4ºC. The aqueous 
phase containing RNA was transferred to a new tube and RNA precipitated with 500 µL of 
isopropanol for 15 min at room temperature. Then the solution was centrifuged at 12,000 g 
for 10 min at 4ºC and the pellet was washed with 1 mL of ice-cold 75% (v/v) ethanol and 
re-suspended in 40 µL 60ºC heated Storage Solution RNAse free (Ambion, Foster City, 
CA, USA). The RNA concentration was determined by OD260 measurement using a 
Nanodrop spectrophotometer (Wilmington, DE, USA). Quality was monitored for absence 
of genomic DNA, protein or guanidine isotiocianate contamination through assessment of 
260/280 and 260/230 ratios.  
6. qRT-PCR 
For the synthesis of cDNA the NZY First-Strand cDNA Synthesis Kit (NZYTech, 
Lisbon, Portugal) was used according to manufacturer instruction. Briefly, 2 µL of random 
primers and the necessary volume of RNAse-free water to complete 15 µL were added to  
1 µg of total RNA. After this, 10 µL of NZYRT 2x Master Mix, 2 µL of NZYRT Enzyme 
Mix and 20 µL of DEPC-treated H2O were added to each sample. A protocol for cDNA 
synthesis was run on all samples (10 min at 25ºC, 30 min at 50ºC, 5 min at 85ºC and then 
chilled at 4ºC). Quantitative Reverse Transcription Polychain Reaction (qRT-PCR) was 
 31 
performed in 20 µL reaction volume: cDNA (25 ng), 10 µL 2x SensiMix™ SYBR® 
(Bioline, MA, USA), 2 µL of each primer (250 nM) and 3.5 µL RNAse free H2O. A 
protocol for cDNA amplification was run on all samples (10 min at 95ºC and 40 cycles of: 
15 sec at 95ºC, 15 sec at 55ºC and 20 sec at 72ºC). qRT-PCR reactions were run in 
duplicate for each sample on a Bio-Rad CFX Connect™ Real Time PCR detection system. 
Primers were designed using Beacon Designer software v8.0, from Premier Biosoft 
International. Primer sequences used are given in Table 5. On RT-PCR plate there was a 
non-template control for each pair of primers analysed. For determination of specific 
efficiencies, a 4 points dilution series of control sample for each pair of primers was run on 
each experiment. After amplification, a threshold was set for each gene and Ct-values were 
calculated for all samples. Gene expression changes were analysed using the built-in Bio-
Rad CFX Manager 3.1 from Bio-Rad.  
Table 5 – Primer sequences used for qRT-PCR analysis. 
Gene 
Name 
Forward primer Reverse Primer 
GADPH ACAGTCAGCCGCATCTTC GCCCAATACGACCAAATCC 
HPRT1 TGACACTGGCAAAACAATG GGCTTATATCCAACACTTCG 
TATA TTCCACTCACAGACTCTC ACAATCCCAGAACTCTCC 
IL1β GCTTGGTGATGTCTGGTC GCTGTAGAGTGGGCTTATC 
IL6 ACCTCAGATTGTTGTTGT GTCCTAACGCTCATACTT 
IL8 CTTTCAGAGACAGCAGAG CTAAGTTCTTTAGCACTCC 
CD83 ATTGAGTCATTATCCTTGCTAT GCTTCTTGGTAACCTTCTT 
CD86 GAACCTAAGAAGATGAGT TCCAGAATACAGAAGATG 
CHOP CTGGAAGCCTGGTATGAG GGTCAAGAGTGGTGAAGAT 
ATF4 AGATAGGAAGCCAGACTA CTCATACAGATGCCACTA 
GRP78 TTACTTAGATTGTGTTCCT TCTCTATCTCTTGACCTT 
VEGFA TTACTCTCACCTGCTTCT CTGCTTCTTCCAACAATG 
CXCL14 TTCCAAGATCCTGTGATG TATTGAACCTGTGAACCTT 
VEGFB ATCTACTGAGTGACCTTG TTCTGTTCCCTCTATGTG 
 
7. Exosomes isolation and purification 
T-47D cells were grown in aforementioned conditions (Table 4, section 1) Cell 
Culture), in which bovine exosomes have been depleted from media. For cell debris 
removal, initial volume of 12 mL was centrifuged at 370 g for 10 min at 4ºC. The 
supernatant was centrifuged again at 16,000 g for 30 min at 4ºC. Then, exosomes were 
isolated from conditioned medium with Exo-spin™ kit (Cell Guidance Systems, Carlsbad, 
CA, USA). Briefly, to precipitate the exosome containing fraction, 5 mL of Buffer A from 
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was added to 10 mL of supernatant. Gentle inversion was performed to ensure proper 
mixing which was then incubated overnight at 4ºC. Following a centrifuge of 20,000 g for 
1h, the supernatant was carefully removed and discarded. The left exosome containing 
pellet was re-suspended in 100 µL 1x PBS. Finally, to purify the exosome-containing 
solution, the re-suspended exosomes was eluted in spin column (provided with the kit). 
Ultracentrifugation was also performed in order to remove exosomes from conditioned 
medium and assay the effect of conditioned medium depleted from T-47D-exosomes, 
following Thèry et al protocol [82]. 
8. Transmission Electron Microscopy (TEM) Analysis 
Exosomes were observed by Transmission Electron Microscopy (TEM). For TEM 
analysis, 20 mL of bovine exosomes depleted conditioned medium (from around 20 x 10
6
 
T-47D cells) was recovered and T-47D-exosomes were isolated as previously described 
purified exosomes pellet was firstly fixed and then contrasted and embed on electron 
microscopy grids following Thèry et al protocol [82]. Briefly, 20 µL of paraformaldehyde 
(PFA) 4% was added to exosome-containing eluate (20 µL) and 5 µl deposited onto 
Formvar-carbon coated EM grids. Exosome-coated vesicle were washed with 100 µL of 1x 
PBS and after 50 µL of 1% glutaraldehyde for 5 minutes. The grids were then washed 8 
times with distilled water with stand periods of 2 minutes. Following the fixation process, 
samples were contrasted and embedded: 50 µL of uranyl-oxalate pH 7 were transferred to 
the grids and incubated for 5 minutes; then grids were embedded in a mixture of 4% uranyl 
acetate and 2% methyl cellulose (100 µL/ 900 µL). Grids were then incubated with 50 µL 
of methyl cellulose-UA for 10 minutes, on ice. Finally, the grids were dried and observed 
under the electron microscopy at 80kV. 
9. Statistical analysis 
The results are presented as mean ± S.D., and the statistic difference between two 
groups was determined by the two-sided unpaired Student’s t test. The tests were 
performed using GraphPad Prism, version 5.02 (GraphPad Software, San Diego, CA, 
USA). Statistically significant values are as follows: *p <0.05, **p <0.01, ***p <0.001, 
****p <0.0001   
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Results and Discussion 
 
Chapter I - Unravelling the possible mechanisms of Transmissible 
Endoplasmic Reticulum Stress phenomena 
 
In order to evaluate our hypothesis that ER stressed cancer cells may transmit ER 
stress factors to other cells (transmissible ER stress (TERS)) modulating that way their 
microenvironment, we performed several experiments to: 1) optimize a pharmacological 
and a physiological ER stress-induced model; 2) evaluate TERS in monocytes; 3) assess 
monocytes modulation by TERS; 4) elucidate the vehicle by which TERS occurs. Initially 
we optimized the effect of either tunicamycin and glucose deprivation on cells, 
establishing an ER stressed cancer cell model. Then we evaluate the transmission of ER 
stress from cancer cells to monocytes, either by using total conditioned medium or isolated 
exosomes. Finally we assessed the effects of ER stress-derived exosomes on monocytes 
activation status and inflammatory phenotype. 
 
1. High concentrations of tunicamycin do not induce relevant cytotoxicity in    
T-47D cells 
Tunicamycin (TUN) is commonly used as a positive inducer of ER stress, leading to 
UPR activation in several cell types. Briefly, tunicamycin is an antibiotic that inhibits 
protein N-glycosylation resulting in the accumulation of misfolded proteins in the ER 
lumen [83]. As a result, ER membrane transducers, IRE1, ATF6 and PERK are activated 
and trigger the three UPR-branches that culminate in the overexpression/phosphorylation 
of some ER stress protein markers such as GRP78, CHOP, ATF4, p-eIF2α, among others 
[63,83–85]. To prevent death events due to over dosage we assessed in a first stage of our 
experiments, the impact of tunicamycin on breast cancer cells (T-47D) viability using 
resazurin. Resazurin is a non-toxic blue dye that is used to detect NADH, released by 
metabolic active cells. Through a redox reaction, resazurin turns into a pink oxidized 
compound, resofurin, possible to quantify by spectrophotometry 
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From our results, T-47D cells showed to be resistant to high concentration of 
tunicamycin. Even the highest concentration tested (10 µg/mL) just resulted in a slight 
decrease of cell viability (Figure 7). In fact, this slight decrease may even result from a 
diminished mitotic process caused by tunicamycin rather than from cell death. Thus, to 
maximize cells response to the drug, we decided to use an elevated concentration of 
tunicamycin.  
 
2. Tunicamycin, glucose deprivation, acidosis and phenantroline induce ER 
stress in T-47D breast cancer cells 
As previously described, UPR in tumor cells is effectively activated by several 
stimuli such as hypoxia, nutrient deprivation and acidosis among others. To mimic these 
microenvironment factors T-47D cells were incubated for 24h without glucose (-GLU), in 
lactic acidic medium (ACID), with the chemical hypoxia inducers - cobalt chloride and 
phenantroline (CoCl2 or Phe) or with a glucose free acidic medium (-GLU+ACID) (Figure 
8). Induction of ER stress was then monitored by analysis of transcription and expression 
of the UPR-related proteins ATF4, CHOP and GRP78. 
 
 
 
T-47D cells  
 
ER stress stimuli 
Protein/RNA 
extraction 24h 
Figure 7 – Effect of different concentrations of tunicamycin on T-47D cell viability. 3x104 T-47D cells 
were treated with different concentrations (1, 2, 5 and 10 µg/mL) of tunicamycin for 24h. 50 µM resazurin 
were added in the last 4h. The absorbance was then read at 570 and 600 nm in a standard spectrophotometer. 
Figure 8 – Brief scheme of cell treatments. Cells were stimulated for 4/24h for each stimulus (tunicamycin, 
acidosis, glucose deprivation, glucose deprivation and acidosis, phenantroline and cobalt chloride) and then 
protein and/or RNA were extracted. 
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As expected, tunicamycin induced the overexpression of UPR-related proteins, 
namely CHOP, GRP78 and ATF4. Moreover, we observed that tunicamycin effect was 
enhanced at longer incubation times (24h). Hereinafter, tunicamycin was undertaken as our 
experimental positive control for ER stress induction. Consistent with previous reports 
[85,86], we observed that glucose deprivation effectively induced ER stress in T-47D cells 
(Figure 9). Glucose starvation early activates the UPR as shown by the strong increase of 
ATF4 levels at 4h post deprivation. In contrast to tunicamycin, these high ATF4 levels 
were maintained over 24h and resulted in a strong induction of CHOP protein.  Concerning 
lactic acidosis (ACID) stimulus, it is clear the absence of effective UPR activation, as 
visible by the very low levels of CHOP, GRP78 and ATF4 for both 4 and 24h. Lactic 
acidosis has been frequently referred to as a tumor microenvironment ER stress inducer, as 
lactate is an abundant product present in the intercellular space of the solid tumors; 
however little is known relatively to its role in the UPR activation, and relatively few 
studies have reported its relevance. High acidosis (pH 7.0-6.0) reduces ER Ca
2+
 ATPase 
activity, explaining the induction of ER stress, in these conditions [87]. One of the few 
studies linking ER stress and acidosis reported that astrocytes cultured at pH 6.0 
overexpress GRP78 [88]; however tumor microenvironment pH ranges between 7.0 and 
6.5 [89], and this milder acidosis seemed to not induce ER stress in T47-D cells (Figure 9).  
Surprisingly, T-47D cells grown in medium without glucose combined with lactic 
acidosis (25 mM lactic acid, pH 6.5) seemed to present lower levels of ER stress compared 
C 
TUN 
4h 
TUN 
24h 
ACID 
4h 
ACID 
24h 
-GLU 
4h 
-GLU 
24h 
-GLU 
+ACID 
4h 
-GLU 
+ACID 
24h 
Phe 
4h 
Phe 
24h 
CoCl2 
4h 
CoCl2 
24h 
CHOP 
GRP78 
ATF4 
Figure 9  - Effect of tumor environment factors (or mimics) and tunicamycin on the levels of CHOP 
GRP78 and ATF4 proteins. T-47D cells were stimulated for 4/24h with each stimulus (tunicamycin - 
TUN; acidosis – ACID; glucose starvation - -GLU; glucose starvation and acidosis - -GLU+ACID; 
phenantroline – Phe; and cobalt chloride – CoCl2. After the indicated times, total cell lysates were prepared 
and UPR markers analysed by Western blotting. 
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to glucose deprivation itself (Figure 9). The lower levels of ATF4, GRP78 and CHOP, 
observed  when lactic acid was added to deprived glucose medium suggested us that lactate 
could be used as an alternative energy source, which can protect T-47D towards the ER-
stress induced by lack of glucose. This hypothesis was studied and discussed later, in 
chapter II of this section - Lactic acidosis mitigates glucose deprivation induced-ER stress 
in T-47D cells. 
After this initial screening for identification of effective ER stress modulators, 
tunicamycin as a positive control and glucose deprivation as physiological stress inducer 
were chosen for the design of subsequent experiments. We began by performing a more 
detailed assessment of the effects of tunicamycin and glucose deprivation on the 
expression and transcription of UPR effectors. To do so, we incubated T-47D cells with 
tunicamycin or glucose deprived medium and extracted protein and mRNA at 4 and 24h.  
 
 
 
 
 
 
 
  
(A) 
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C 
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Western blot analysis revealed that ATF4 protein expression highly increases after 
tunicamycin treatment or glucose deprivation (Figure 10A). It is worth to note that ATF4 
protein expression is promptly increased for both stimuli; however high ATF4 protein levels 
were only sustained for glucose deprivation, as in tunicamycin-treated cells ATF4 levels 
substantially diminished at 24h. ATF4 is a bZIP transcription regulator, controlled by eIF2α 
phosphorylation that, in turn, is activated by one of 4 stress sensors, namely ER stress-
related PERK, amino acid deprivation sensor GCN2, infection with double stranded RNA 
viruses (PKR) and heme deficiency (HRI) [49,90]. ATF4 has a relevant role in tumor 
survival, mainly due to its functions as UPR effector protein (upregulating chaperones such 
as GRP78, inhibiting generalized protein synthesis, and inducing the CHOP/GADD34 
apoptotic factors) [44]. Moreover, ATF4 protein has been linked to tumor microenvironment 
modulation, as it was reported to upregulate IL-6 and VEGF (potent angiogenic factors) in 
cancer cells [91]. 
Figure 10 - Effects of tunicamycin and glucose deprivation on the levels of ATF4, CHOP and GRP78 
proteins on cancer cells. (A) T-47D cells were stimulated for 4 or 24h with tunicamycin (TUN) and glucose 
deprived medium (-GLU). Then total protein extracts were prepared and ER stress evaluated through analysis 
of ATF4, CHOP and GRP78 protein levels by Western blotting (B) The results represent at least 3 
independent experiments and were expressed as fold changes relatively to control (untreated cells). *p<0.5; 
**p<0.01; ***p<0.001; ****p<0.0001 
 
(B) 
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As shown in Figure 10A the maximum increase of GRP78 protein in stressed cells 
occurred at longer exposure times (TUN 24h, -GLU 24h). During ER stress, GRP78 
dissociates from the UPR-sensors, IRE1, PERK and ATF6, and bind to misfolded proteins 
to minimize aggregation processes; moreover, the activation of the PERK-UPR branch 
results in a rapid attenuation of mRNA translation in order to prevent the influx of newly 
synthesized polypeptides into the stressed ER [84]. Besides this general translation 
attenuation, specific proteins with uORFs such as ATF4, ATF5, CEBPA and CEBPB are 
selectively translated [49,92]. These transcription factors are responsible for the 
upregulation of some proteins involved in the reestablishment of ER homeostasis, such as 
GRP78, ERP1, and HMOX but also control the expression of pro-apoptotic factors like 
CHOP. CHOP leads the cell to cell cycle arrest and/or apoptosis [93] and is canonically 
viewed as the ultimate event of an intense and long activation of PERK-eIF2-ATF4 UPR 
axis. In our experiments, although increased levels of ATF4 were detected in tunicamycin-
treated cells, concomitant upregulation of CHOP was not observed. Accordingly, Harding 
and co-workers have shown that in Perk-/- fibroblasts, forced ATF4 overexpression in 
absence of an additional stress stimulus was not sufficient for CHOP induction. Therefore, 
our results reinforce the idea that additional stress signals other than those transmitted by 
the PERK-eIF2α-ATF4 branch are required for CHOP induction in response to ER stress. 
Another possible explanation is the partial recovery observed in tunicamycin-treated cells, 
where ATF4 levels significantly decrease after 24h (Figure 10). This hypothesis is also 
supported by the results obtained in glucose deprived cells: given that glucose starvation 
lead to a sustained activation of the PERK-eIF2α-ATF4 this resulted in significant increase 
in CHOP expression (Figure 10). 
Additionally, we analysed the effects of tunicamycin and glucose deprivation in the 
transcription of CHOP, GRP78 and ATF4 genes.   
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In accordance to the results obtained in protein analysis, qRT-PCR data revealed that 
transcription of CHOP and GRP78 was effectively induced either by tunicamycin or 
glucose deprivation (Figure 11). Regarding ATF4 gene we observed that the transcription 
is just slightly upregulated by both stimuli despite the high detected protein levels. This 
indicates that the observed increase of ATF4 protein results from a posttranscriptional 
event. Accordingly, it has been shown that during UPR activation the PERK-dependent 
phosphorylation of eIF2α causes a generalized attenuation of protein translation while 
(B) 
Figure 11 – Effect of tunicamycin (A) and glucose deprivation (B) on CHOP, GRP78 and ATF4 mRNA 
levels. T-47D cells were stimulated with tunicamycin (A) and glucose deprivation (B) for 4 or 24h. RNA was 
extracted and qRT-PCR performed to assess CHOP, GRP78 and ATF4 mRNA levels. The relative expression 
of the indicated genes was normalized using TATA as reference gene.  
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ATF4 translation is enhanced without changes in its mRNA transcription [94,95]. It is also 
worth highlighting that glucose deprivation stimulus requires a longer time of exposure to 
induce a stronger UPR activation on T-47D cells. Glucose deprivation is a milder stimulus 
comparing to tunicamycin that acts by directly inhibiting an essential process for the 
correct protein folding in the ER lumen. Thus its effective action probably requires longer 
incubation time in order to obtain more detectable changes in ER stress profile. Taken 
together, these data reveals that glucose deprivation effectively induces several arms of the 
UPR in T-47D cells and is therefore a good physiological stimulus to study the 
transmissible ER stress phenomena. 
 
3. ER stress strongly induces interleukine-8 upregulation  in breast cancer cells 
The effect of ER stress on cancer cells cytokine profile was also assessed, in order to 
correlate with a possible signalling transmission to THP-1 cells in later experiments. To 
evaluate the expression of several cytokines under ER stress, T-47D cells were stimulated 
for 4 or 24h with each stimulus (tunicamycin or glucose deprivation), mRNA was  
extracted and IL1β, IL8, CXCL14, VEGFA and VEGFB transcription was  analysed by 
qRT-PCR.  
The ER stressors (tunicamycin and glucose deprivation) did not significantly affect 
the cytokine profile of T-47D cells, except for IL8 expression (Figure 12). We observed a 
strong upregulation of IL8 both for tunicamycin (23 fold) and for glucose deprivation (80 
fold) treatment. Cancer cells have a typical inflammatory phenotype, characterized by the 
production and secretion of high levels of proinflammatory mediators as IL-6, PGE2, and 
chemokine as IL-8 and CXCL14, for example [96,97]. These mediators are responsible for 
the tumor growth, neovascularization and all the processes that support tumor survival and 
development. VEGF and IL-8 are potent angiogenic factors and are well characterized in 
human breast cancer [98,99]. Previous studies have shown that ER stress could be 
responsible for the upregulation of the pro-angiogenic factor IL-8 in human breast 
carcinoma [99], namely the axis PERK-eIF2α-ATF4 [100] . It is worth to note that IL-8 is 
strictly regulated by NF-κB cascade, which, in turn, has been associated with the activation 
of eIF2α, establishing that way a connection between UPR activation and NF-kB signalling 
pathways [101]. In fact ER stress-sensors and UPR-related proteins have been linked to the 
regulation of other inflammatory signalling cascades, namely: 1) the upregulation of IL-8 
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through activation of NF-κB mediated by CHOP (PERK-eIF2α-ATF4-CHOP) [102]; 2) 
the upregulation of TNF-α, IL-6, IL-8 and MCP-1 through activation of JNK/p38 MAPK 
pathway by IRE1 (IRE1-TRAF2-ASK1) [103]; 3) the upregulation of TNF-α, TGF-β, IL-
2, IL-6 and IL-8 through activation of NF-kB by IRE1(IRE1-TRAF2-IKK)[104].  
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Figure 12 – Effect of tunicamycin and glucose deprivation in mRNA levels of IL1β, IL8, CXCL14, 
VEGFA and VEGFB. T-47D cells were stimulated with tunicamycin (A) and glucose deprivation (B) for 4 
(white bars) or 24 (grey bars) hours. IL1β, IL8, CXCL14, VEGFA and VEGFB mRNA levels were normalised 
against control (cells unstimulated). 
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4. Conditioned medium from glucose deprived T-47D cells does not induce ER 
stress in THP-1 cells 
Our main goal in this work was to determine how ER stressed breast tumor cells 
could transmit ER stress to other cells present in the tumor microenvironment such as 
macrophages and dendritic cells, in order to modulate their immunostimulatory abilities. 
The concept of  “Transmissible ER Stress” (TERS) was established by Mahadevan and 
collaborators when they observed that conditioned medium (CM) from ER stressed cancer 
cells induced UPR activation in myeloid cells, namely increased expression of GRP78 
[77]. They also observed that myeloid cells cultivated with CM from ER stressed cancer 
cells underwent through an immunosuppressive modulation and also shifted their 
inflammatory profile, namely towards a proinflammatory phenotype. However, the 
mechanisms that outline this transmission were not clarified in none of the referred works.  
As a first approach we recovered the CM from each T-47D growth condition, 
centrifuged it to discard dead cells and cellular remains, and incubated THP-1 cells with 
respective CM for 24 hours, as outlined in Figure 13. 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13 – Schematic representation of the methodology applied to assess transmission of ER stress 
by T-47D-derived CM. ER stress was induced in T-47D cells by tunicamycin- or glucose deprivation-CM. 
After 4h of incubation with tunicamycin, T-47D cells were washed and incubated with fresh medium for 
more 24h. 
T-47D cells  
 
ER stress stimuli: Glucose deprivation 
Recover CM 
 
24h 
THP-1 
cells 
Re-establishment of glucose levels 
and CM incubation 
 
Addition 
24h Protein/RNA 
extraction 
T-47D cells  
 
ER stress stimuli: Tunicamycin 
4h: tunicamycin washing step 
Recover CM 
 
24h 
THP-1 
cells 
24h Protein/RNA 
extraction 
ATF4 
CHOP 
β-tubulin 
C TUN -GLU C TUN -GLU 
- GLU 
+ GLU 
THP-1 + 
Direct stimuli 
THP-1 + 
T-47D CM (A) 
 43 
A T F 4  -  d ir e c t  s t im u l i
E
x
p
r
e
s
s
io
n
 f
o
ld
 c
h
a
n
g
e
 r
e
la
t
iv
e
ly
 t
o
 c
o
n
t
r
o
l
C
o
n
tr
o
l
T
U
N
G
L
U
0
5
1 0
1 5
2 0
**
A T F 4  -  C M
E
x
p
r
e
s
s
io
n
 f
o
ld
 c
h
a
n
g
e
 r
e
la
t
iv
e
ly
 t
o
 c
o
n
t
r
o
l
C
M
-C
o
n
tr
o
l
C
M
-T
U
N
C
M
-G
L
U
C
M
-G
L
U
+
G
L
U
0
2
4
6
8
****
 
 
 
 
  
 
 
 
As shown in Figure 14, conditioned medium from tunicamycin-treated T-47D cells 
effectively induced ER stress in THP-1 recipient cells. This result was in agreement with 
the previous study of Mahadevan and collaborators, and suggests that ER stress may be 
transmitted between cells through some soluble factors released into the 
microenvironment. In the referred study, several cancer cell lines were treated with  
thapsigargin (a pharmacological ER stress inducer) and their conditioned medium was 
used to culture  myeloid cells [42]. The activation of the UPR in recipient cells was 
demonstrated by the increased transcription of GRP78, CHOP, and XBP1-s. In the same 
study, the authors also performed a punctual experiment where they induced ER stress in 
cancer cells by glucose deprivation. They used this glucose free conditioned medium to 
culture myeloid cells and observed that they also developed characteristics of ER stress. As 
the mRNA levels of ER stress markers such as CHOP, GRP78 and XBP1-s were slightly 
higher in cells that received the glucose free conditioned medium compared to cells 
directly cultured in fresh medium without glucose, they concluded that ER stress was also 
transmitted in these conditions (11). However, in our perspective, a key experimental 
condition was lacking in these experiments: myeloid cells cultured in conditioned medium 
from glucose starved cancer cells but where the levels of glucose were re-established prior 
treating the myeloid cells (glucose 25 mM). To clarify this hypothesis we performed an 
Figure 14 - Effects of glucose deprivation- and tunicamycin-CM on the levels of ATF4 protein in 
THP-1 cells. (A) THP-1 cells were incubated for 24h with glucose deprivation-CM (with reposition of 
glucose, CM-GLU+GLU or without, CM-GLU) and tunicamycin-CM (CM-TUN). Direct stimulation with 
ER stressors was also performed to control THP-1 responsiveness. (B) The results represent at least 3 
independent experiments (except for CM-TUN that represents only 1) and were expressed as fold changes 
relatively to control (cells without any treatment). *p<0.1; **p<0.01; ****p<0.0001 
 
(B) 
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assay to compare both the procedures: an experiment in which we restored the glucose 
levels to 25 mM (CM-GLU+GLU), and a second one, reproducing Mahadevan work 
conditions, in which THP-1 cells were incubated with glucose deprived conditioned 
medium without reestablishment of glucose levels (CM-GLU). As shown in Figure 14, 
THP-1 cells cultured in glucose free T-47D-conditioned medium (CM-GLU) present 
increased levels of ATF4, and these levels are slightly higher than in cells directly 
deprived. This slight overexpression may be related to the presence of soluble factors, such 
as cytokines, released by ER stressed T-47D cells and present on CM-GLU. However, if 
glucose is restored (CM-GLU+GLU) this effect is almost completely abolished. These 
results clearly evidence that in cells cultured in the glucose free conditioned medium the 
development of ER stress is mainly a direct consequence of the lack of glucose rather than 
a transmission of UPR-involved signalling factors.  
Of note is the fact that even though glucose deprivation (direct stimulus) also caused 
ER stress in THP-1 cells, the levels of UPR effectors such as ATF4 and CHOP (Figure 14) 
were substantially lower than the ones observed in T-47D cells (Figure 10). Despite the 
high requirements of cancer cells for glucose-dependent metabolism [8], THP-1 cells are 
characterized with a lower proliferative rate and glycolytic activity, which results in a 
lower dependence of glucose. These metabolic characteristics may explain the different 
response magnitude towards glucose levels observed for T-47D and THP-1 cells.  
From our results an intriguing question arises: if tunicamycin and glucose 
deprivation are equally effective in inducing ER stress in T-47D cells why ER stress 
transmission was only observed in tunicamycin-CM recipient cells?  The most plausible 
explanation may be the co-transport of the drug by the conditioned medium either as free 
tunicamycin or vesicle-associated tunicamycin. Mahadevan and collaborators have 
excluded the hypothesis of thapsigargin (also a pharmacological ER stress inducer) co-
transport through CM once mass spectrometry analysis did not shown any peak relative to 
this compound; however, they analysed an extremely low CM volume (300 µL), leading to 
a possible misconception of the presence of the drug in CM, which concentration could be 
under the detection limit of the technique. 
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5. Characterization of T-47D cell-derived exosomes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To clarify the possible mechanism of ER stress transmission observed in tunicamycin 
conditioned medium we decided to isolate the stressed T-47D cell-derived exosomes 
(Figure 15). Exosome isolation has become a very useful procedure in research, due to 
interesting findings regarding the role of these small vesicles in cell-cell communication. 
The most ancient method to isolate exosomes (and the most used) is the ultracentrifugation 
process; however it requires an ultracentrifuge machine, is extremely time consuming and 
usually results in very low yields of exosomes [105]. We opted to use a recent developed 
exosome isolation kit from Cell Guidance Systems in order to achieve higher yields of 
purified exosomes. The classical characterization of exosomes is based on the size (around 
50-200 nm of diameter), the morphology (round shaped membrane vesicles (reviewed in 
[79])) and the presence of some membrane surface proteins, such as CD81 and CD63 
[106]. Thus we performed Western blot technique to detect these two markers (Figure 16).  
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Figure 15 – Schematic representation of the methodology applied to isolate T-47D ER stress exosomes. 
ER stress was induced in T-47D cells by tunicamycin (A) and glucose deprivation (B). After 24h, exosomes 
were isolated and purified from the CM of T-47D ER stress cells with Exo-spin™ kit. 
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Parent cells Exosomes 
C    TUN   -GLU C     TUN   -GLU 
Glycosilated CD63 
Unglycosilated CD63 
CD81 
ATF4 
GRP78 
Figure 16 - Characterization of exosome by Western blot. Samples were tested for typical exosomal 
markers, CD81 and CD63, and also for UPR markers, as ATF4 and GRP78. Parent cells were stimulated 
with tunicamycin and glucose deprivation medium  and the released exosomes were isolated from 
conditioned medium after 24h using Exo-spin™ kit. Parent cells Western blots were performed to 
comparision with exosomal fraction. 
 
 
 
 
 
 
 
As presented in Figure 16, protein extracts from exosomes (from control-, 
tunicamycin- and glucose deprivation-conditioned medium) shown to be enriched in CD81 
and CD63 tetraspanins compared to the respective parent cells. Additionally, we observed 
that in exosomes from tunicamycin-treated cells CD63 is present in both unglycosylated 
(25kDa) and glycosylated (36 to 60kDa) forms [107]. This particular result indicates that 
tunicamycin is inducing ER stress in parent cells, by effectively inhibiting the N-
glycosylation of proteins, leading to the accumulation of misfolded proteins in the ER 
lumen. Moreover, this finding also demonstrates that exosomes from ER stressed cells 
carry protein factors that reflect the condition of the cells that originate them. 
Exosomes are only possible to directly visualize through electron microscopy due to 
their small size. Thus, we performed an observation of the ultrastructure of putative 
exosomes using Transmission Electron Microscopy (TEM). In Figure 17 we can observe a 
representative TEM image of the isolated nano vesicles.  
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The majority of the visualized vesicles (Figure 17) were within 40-200 nm size 
range, indicative of exosomes [106,108], suggesting that our exosomes were successfully 
purified. 
In order to understand the factors beneath exosomal action in THP-1 cells, we 
performed an electrophoretic separation of exosomal and parent cells proteins (Figure 18). 
 
 
  
Figure 18 – SDS-PAGE gel electrophoresis of the proteins from T-47D total cell lysates and T-47D cell-
derived exosomes from different treatments (tunicamycin and glucose deprivation). T-47D cells were 
Figure 17 – Representative Transmission Electron Microscopy image of T-47D-derived exosomes 
ultrastructure. Exosomes were isolated from T-47D cells grown in RPMI medium by Exo-spin™ kit. 
Morphologically the exosome-like vesicles are within the typical size range ((A) ~160 nm, (B) 60-140 nm), 
spherical and limited by a well-defined lipid layer. (B) Observation of cup-shaped morphology is also typical 
in exosome TEM images. 
(A) (B) 
C TUN -GLU C TUN -GLU 
Exosomes Parent Cells 
75 kDa 
25 kDa 
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incubated with tunicamycin and/or glucose deprived medium (tunicamycin was washed after 4h of 
incubation). After 24h, exosomes were isolated and purified as well as total cell lysates. 50 µg of protein 
were then run on SDS-PAGE gel. 
Despite the protein identification is still in progress, we expect to see relevant 
differences between control and stressed exosomes. It is clear that bands pattern namely for 
glucose deprivation exosomes, is slightly different from both tunicamycin and control 
exosomes: we can observe the appearance of a new band at approximately 25kDa as well 
as the absence of a 37 kDa band. These inferences are only plausible with the support of 
protein identification and quantification, which is already in progress by MALDI analysis. 
 
6. Exosomes from glucose deprived T-47D cells do not induce ER stress in  
THP-1 cells 
The role of tumor-derived exosomes has been increasingly studied and discussed. 
Earlier studies demonstrated that tumor-derived exosomes essentially carry tumor antigens, 
which result in enhanced activation of immune responses; however, recently the link 
between cancer cells-derived exosomes and tumor growth and development has been 
focused in possible immunosuppressive abilities. To identify the effects of T-47D-derived 
exosomes on the modulation of dendritic cells, and the possible transmission of ER 
stressors we first evaluated the UPR activation in recipient THP-1 cells. To that end, we 
isolated the exosomes originated from tunicamycin or glucose deprived T-47D cells and 
cultured monocytes with purified exosomes for 24h (Figure 19).  
 
 
 
 
 
 
T-47D cells  
 
ER stress 
stimuli 
24h Exosomes 
isolation 
THP-1 
cells 24h 
Protein/RNA 
extraction 
Figure 19 – Schematic representation of the methodology applied to assess THP-1 induced ER stress by 
T-47D-derived exosomes. ER stress was induced in T-47D cells by tunicamycin and glucose deprivation. 
After 24h of incubation, exosomes were isolated and purified from ER stress CM and THP-1 were incubated 
for 24h with the respective eluate-containing exosomes. 
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The protein analysis showed that exosomes from tunicamycin treated cells induced a 
significant increase of ATF4 expression (5.548 ± 0.9027) in THP-1 recipient cells (Figure 
20). This result may explain the observed transmission of ER stress when cells were 
exposed to tunicamycin conditioned medium and strongly advises against the TERS 
phenomena. Moreover exosomes from glucose deprived medium (E-GLU) did not induce 
relevant differences relatively to the control. Thus, it seems that the transmission of ER 
stress is only noticeable when pharmacological inducers such as tunicamycin or 
thapsigargin are used. This results not from the transmission of some cell stressor factors 
but from the transmission via exosomes of the drugs itself. To further investigate if ER 
stress was induced via exosomal carrying, we analysed the ATF4 levels on THP-1 cells 
incubated with tunicamycin stressed T-47D cells secretome: complete conditioned 
medium, conditioned medium depleted from exosomes and isolated T-47D cells-derived 
exosomes (Figure 21). As expected, we observed that cells exposed to exosomes-depleted 
medium showed a dramatically decrease of ATF4 levels (Figure 22). Thus we can 
conclude that the factor responsible for the induction of ER stress in THP1 cells is within 
the exosomes.  
 
 
ATF4 
β-tubulin 
C TUN -GLU C E-TUN E-GLU 
THP-1 +  
T-47D Exosomes 
THP-1 +  
Direct Stimuli 
(A) (B) 
Figure 20 - Effect of exosomes from tunicamycin- and glucose deprived-T-47D cells on UPR activation 
in THP-1 cells. (A) THP-1 cells were incubated with exosomes from the respective T-47D-stimulated ER 
stressor (tunicamycin (E-TUN) or glucose deprivation medium (E-GLU)) for 24h as schematized in Figure 
19. Western blotting was performed to assess ATF4 protein expression. For reference THP-1 cells were also 
directly stimulated with each stimulus (TUN and –GLU) for 24h, in the same conditions. (B) The results 
represent 4 independent experiments and were normalized against control (cells untreated). **p<0.01 
 
 50 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 22 - Effect of differential secretome from tunicamycin-treated T-47D cells on UPR activation in 
THP-1 cells. THP-1 cells were incubated with conditioned medium (CM), conditioned medium depleted 
from exosomes (CM-EXO) and exosomes (EXO) from T-47D cells stimulated tunicamycin with for 24h as 
schematized in Figure 21. Western blotting was performed to assess ATF4 protein expression. For reference 
THP-1 cells were also stimulated with tunicamycin (TUN) for 24h, in the same conditions.  
UPR-related gene expression was also investigated by evaluating ATF4, CHOP and 
GRP78 mRNA levels through qRT-PCR. In accordance to the protein data, tunicamycin-
related exosomes induced the upregulation of ATF4, GRP78 and CHOP mRNA on THP-1 
cells (E-TUN) (Figure 23). Again, this effective induction of ER stress through exosomes 
from T-47D cells treated with tunicamycin corroborates our previously formulated 
hypothesis, that tunicamycin could possibly be transported inside exosomes. On the other 
hand, the transcription of studied genes did not increased significantly in cells treated with 
glucose deprivation-related exosomes (E-GLU). Thus, we can conclude that T-47D cells 
C TUN CM 
CM -
EXO EXO 
ATF4 
 
THP-1 
cells 
24h Protein/RNA 
extraction 
T-47D cells  
 
ER stress stimuli: Tunicamycin 
4h: tunicamycin washing 
step Recover 
CM 
 
24h 
THP-1 
cells 
24h Protein/RN
A extraction 
Exosomes 
Conditioned medium 
depleted from exosomes 
Ultracentrifugation 
T-47D cells  
 
ER stress stimuli : Tunicamycin 
4h: tunicamycin washing step 
Recover CM 
 
24h 
THP-1 
cells 
24h Protein/RN
A extraction 
(A) 
(B) 
Figure 21 - Schematic representation of the methodology applied to assess THP-1 induced ER stress by 
T-47D-derived differentially secretome. ER stress was induced in T-47D cells by incubation for 4h. Then 
T-47D cells were washed with fresh medium. After 24h of incubation, conditioned medium was recovered 
and THP-1 were incubated for 24h with exosomes (A), conditioned medium depleted from exosomes (A) and 
complete conditioned medium (B).  Exosomes were isolated from conditioned medium by 
ultracentrifugation. 
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are not able to transmit ER stress through exosomal carrying at least for physiological 
inducers. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7. T-47D cell-derived exosomes modulate THP-1 cells cytokine production and 
maturation status  
As previously suggested, ER stressed T-47D-derived exosomes could be playing an 
important role in the immunosuppression of dendritic cells. In order to study the 
modulation of DCs phenotype, we evaluated the mRNA levels of several inflammatory 
cytokines and chemokines (IL1β, IL6, IL8) and also a maturation marker (CD86) by qRT-
PCR. Additionally, in a parallel experiment, THP-1 cells were pre-treated with LPS (a 
Figure 23 - Effect of tunicamycin- and glucose deprivation-exosomes on ATF4, CHOP and GRP78 
mRNA levels in THP-1 cells. THP-1 cells were incubated with exosomes from the respective T-47D-
stimulated ER stressor (tunicamycin (E-TUN) or glucose deprivation medium (E-GLU)) for 24h as 
schematized in Figure 19. qRT-PCR was performed to assess ATF4, CHOP and GRP78 mRNA expression.  
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potent activator of immune system) in order to increase the magnitude of the observed 
differences, and also to understand the effect of exosomes on cell response.  
DCs treated with E-GLU did not show significant variation of cytokine expression 
(Figure 24), except for IL1β mRNA which was slightly down-regulated (9.6 fold). Despite 
we acknowledge the unresponsiveness of THP-1 cells to glucose deprivation (direct 
stimulation and/or through exosome incubation), we observed a different expression 
profile when THP-1 cells were pre-treated with LPS, namely downregulation of CD86 (1.5 
fold) and IL6 (15 fold) and upregulation of IL1β (1.5 fold) and IL8 (1.8 fold). This suggests 
that E-GLU induces a slight modulation in THP-1 cells, which is only detectable when 
monocytes are activated. The decreased expression of CD86 is characteristic of tolerogenic 
dendritic cells, which are incapable to polarize T cells through a cytotoxic phenotype. High 
levels of tolerogenic dendritic cells lead to an accumulation of CD4
+
CD25
+
FOXP3 
regulatory T cells [34,109]. This immunoescape mechanism is a consequence of tumor-
derived exosome modulation, as revealed by Yu and co-workers. They observed that 
tumor-derived exosome attenuated DC differentiation and CD11
+
c DCs were characterized 
by low levels of CD86 protein [109]. As UPR activation was not detected in THP-1 
incubated with E-GLU (Figure 23) we can propose that THP-1 modulation is ER stress-
independent and must result from the transport of cancer-associated factors, as cytokines 
and/or microRNA. In turn, upregulation of IL8 is very prominently on THP-1 cells 
incubated with E-Control and E-GLU. IL-8 is a hallmark chemokine of tumor pro-
inflammatory mediators, known by its potent angiogenic character [99]. Our analysis of 
inflammatory profile in stressed and unstressed T-47D cells (Figure 12) reported an 
upregulation of IL8 mRNA in both tunicamycin-treated and glucose deprived cells. In 
conformity with our results, Baj-Krzyworzeka and collaborators showed high levels of IL8 
mRNA within tumor-derived microvesicles, being this related to the observed modulation 
of monocyte cytokine production [110]. This parallelism between IL8 mRNA levels in T-
47D (Figure 12) and THP-1 cells (Figure 24) indicates that tumor-released exosomes can 
be driving THP-1 cells towards a supportive role on the angiogenic demand of T-47D 
cells. 
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Figure 24 – Effect of T-47D cells-derived exosomes in CD86, IL1β, IL6 and IL8 mRNA levels of THP-1 
recipient cells. THP-1 cells were incubated with exosomes derived from ER stressed T-47D cells or 
unstressed cells for 24h (A, C, E, G). In parallel, THP-1 cells were pre-stimulated with LPS for 4h before 
(A) (B) 
(C) (D) 
(E) (F) 
(H) (G) 
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incubation with exosomes (B, D, F, H). Therefore, qRT-PCR was performed for detection of CD86 (A,B), 
IL6 (C,D), IL1β (E,F) and IL8 (G,H)  mRNA cytokines. 
 
As expected, E-TUN induced a generalized upregulation of proinflammatory 
mediators, such as IL6 (80 fold) and IL8 (2.7 fold) and maturation marker CD86 (2.7 fold). 
Basal levels of cytokines (IL6, IL8 and IL10) mRNA were already reported to be 
significantly higher in ER stressed cells [111]. It is important to note the similarity of 
cytokine regulation pattern observed for THP-1 incubated with E-TUN and direct 
stimulation with tunicamycin, except for the upregulation of IL8 in E-TUN; once again 
these results support our hypothesis that tunicamycin is transported through exosomal-
carrying and directly stimulates THP-1 cells. Thus, it is plausible to assume that cytokine 
upregulation in THP-1 cells is a direct consequence of tunicamycin action in monocytes, 
and consequently, an ER stress-dependent modulation. Nonetheless after pre-treatment 
with LPS, E-TUN downregulates cytokine and CD86 mRNA expression in THP-1 cells, 
indicating an attenuation of the inflammatory phenotype. ER stress is highly associated 
with inflammatory mechanisms, namely the activation of NF-κB cascade [70]. As recently 
reported by Zhang and collaborators, ATF4 plays a crucial role on TLR4 signalling, 
resulting on enhanced cytokine production [112]; however, the effect of tunicamycin, a 
pharmacological ATF4 inducer, results on inhibition of NF-κB cascade on THP-1 cells 
treated with LPS. This inhibition was explained by the deleterious effect of tunicamycin in 
TLR4 signalling, attenuating the proinflammatory cytokines expression [113].  
Overall our data indicates that TERS phenomena seems to be a misconception 
resultant from the transport of pharmacological inducers (tunicamycin in this particular 
case) within the exosomes and the direct UPR activation in monocytes. We also 
acknowledged that, despite exosomes from glucose deprived cells are not able to induce 
ER stress on target cells, they efficiently modulate the inflammatory profile and maturation 
status of THP-1 cells. 
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ATF4 
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Figure 26 – Effect of glucose deprivation, lactate, hydrochloride acid and conjugation of each acid 
with glucose deprivation on ATF4, CHOP and GRP78 protein levels of T-47D cells. T-47D cells 
were stimulated for 24h with glucose deprived medium (-GLU), RPMI 10% FBS supplemented with 
25mM lactate pH6.5 (Lact), hydrochloride acid pH6.5 (HCl), glucose deprived medium + 25mM lactate 
pH6.5 (-GLU+Lact) and glucose deprived medium + hydrochloride acid pH6.5 (-GLU+HCl). Then, total 
protein extracts were prepared and ER stress evaluated through analysis of ATF4, CHOP and GRP78 
protein levels by Western blotting.  
Chapter II - Lactic acidosis mitigates glucose deprivation-ER stress in   
T-47D cells 
In our first approach to induce ER stress in T-47D cells (Figure 9), we tested 
different conditions normally present in solid tumor microenvironment such as glucose 
deprivation and lactic acidosis. Surprisingly, we observed that cells simultaneously 
cultured in glucose deprived medium and lactic acidosis (pH 6.6, 25mM lactic acid), 
presented significantly low levels of ER stress than solely glucose deprived cells. After 
exploring some literature we decided to, parallel to the main aim of this project, perform 
some experiments to clarify a possible mitigation of glucose deprivation-ER stress, driven 
by lactate. To further study this possible mechanism, we compared the effect of lactate, 
glucose deprivation + lactate and glucose deprivation + hydrochloride acid (HCl), an 
inorganic acid.  
 
 
 
 
Both lactate and HCl stimulation did not induce relevant levels of ER stress in cancer 
cells, as mentioned and discussed earlier. On the contrary, glucose deprivation efficiently 
induces ER stress, reflected by the overexpression of ATF4, GRP78 and CHOP; however, 
we observed a diminished expression of the aforementioned proteins in glucose 
deprivation + lactate cultured cells (-GLU+Lact) (Figure 26). We also analysed the effect 
of lactate in glucose deprived cells mRNA levels which were congruently with the protein 
data (Figure 27).  
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Accordingly to our hypothesis, mitigation of glucose deprivation-induced ER stress 
is not dependent of pH per se, as the acidification of glucose deprived medium with an 
inorganic acid (-GLU+HCL) did not revert the ER stress caused by the lack of glucose. We 
hypothesise that this mitigation could be consequence of a shift on cells metabolism, as 
lactate could be used as energy source in conditions where supply of glucose is restricted 
starved. Lactate is an organic acid and the principal product of anaerobic respiration in 
muscle cells under exercise endurance, low pO2 and also glycolytic cancer cells [7]. The 
energy metabolism in tumor cells is peculiar and a subject of several studies, some of them 
quite controversial [114–118]. The traditional approach of cancer metabolism is based on 
the dysfunction of mitochondrial respiration, even in normoxic environment - the Warburg 
effect. To cross this impairment, cell forwards the glycolytic products (pyruvate) to the 
Figure 27 – Effect of glucose deprivation, lactate and conjugation of lactate with glucose deprivation 
on levels of ATF4, CHOP and GRP78 mRNA. T-47D cells were stimulated for 24h with glucose deprived 
medium (-GLU), lactate (Lact) pH6.5 and glucose deprived medium + lactate pH6.5 (-GLU+Lact). RNA was 
extracted and qRT-PCR performed to assess ATF4, GRP78 and CHOP mRNA levels. The relative expression 
of the indicated genes was normalized using TATA as reference gene 
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action of lactate dehydrogenase (LDH), allowing cell to produce energy from glucose and 
resulting in the production of ATP and lactate, as final products [7,119]. Cancer cells have 
an extremely high proliferative rate and therefore an increased consumption of glucose. 
This demand is supported by the increased expression of glucose transporters (GLUT1) 
and also glycolytic and lactate dehydrogenase enzymes. Additionally, the resultant lactate 
molecules are transported to extracellular space through monocarboxylate transporters 
(MCT4) [120]. Despite this typical and well-known metabolic characterization, recent 
studies have suggested a new mechanism by which glucose metabolism is driven within 
the tumor microenvironment, the reverse Warburg effect [121]. This theory is based on the 
induction of Warburg effect in stromal cells of the tumor, by epithelial cancer cells. Cancer 
cells release high amounts of ROS that have an impact on stromal cells promoting 
oxidative stress and impaired mitochondrial respiration [122]. Aerobic glycolysis is 
favoured in stromal non-cancer cells and the final product, Lactate, is transported to the 
extracellular space. Then, cancer cells uptake these lactate molecules and use it as the 
preferred energy source, favouring the tricarboxylic acid (TCA) pathway [9,123]. Indeed, 
our results suggested that T-47D cells are not starved; we performed an 
immunofluorescence assay and did not detect apoptotic or necrotic cells in the GLU+Lact 
treatment (data not shown). Moreover, the lactate-dependent mitigation of ER stress in 
glucose deprived cells lead us to postulate that lactate could be re-directed to 
gluconeogenesis pathway in order to support cell grow and normal protein glycosylation. 
Recently two interesting reports have shown that mitochondrial phosphoenolpyruvate 
carboxykinase (PEPCK-M), a gluconeogenesis key enzyme present mainly in hepatocytes, 
is overexpressed in cancer cells [124,125]. Leithner and collaborators reported an 
enhanced expression and activity of PEPCK-M in lung cancer cells under low glucose 
conditions. Moreover they also labelled lactate and observed an accumulation of 
phosphoenolpyruvate, a precursor of gluconeogenesis, concluding that lactate may be used 
as gluconeogenic precursor in low glucose environment [124]. The mechanisms 
responsible for the PEPCK-M overexpression in those conditions are still unclear; however 
Mendez-Lucas and co-workers proposed that activation of GCN2-eIF2α-ATF4 and PERK-
eIF2α-ATF4 (by amino acid depletion or UPR activation, respectively) have a crucial role 
in the signalling PEPCK-M expression [125].  
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With this parallel experiment we aimed to assess a potential mechanism and 
interaction driven by tumor cells in the scope of energy metabolism. As discussed before, 
we assumed that glucose deprivation would induce ER stress in cancer cells due to the 
impossibility to forward proteins through N-glycosylation. Therefore, the low ER stress 
levels observed in glucose deprived cells supplemented with lactate suggest that lactate is 
being driven through gluconeogenesis pathway, which increase the available glucose in the 
cell. Moreover, as T-47D cells continued to grow, it is plausible to hypothesize that lactate 
is also being used to ATP production through tricarboxylic acid cycle (TCA) – oxidative 
phosphorylation (OXPHOS) respiration. These two active pathways (gluconeogenesis and 
TCA-OXPHOS) are expected to be highly regulated in cells with high metabolic demands 
and it would be interesting to elucidate in future works the role of lactate in tumor survival.   
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Concluding remarks 
With the present work we can conclude some important aspects of tumor 
microenvironment: 
 High levels of tunicamycin induce ER stress in T-47D cells; 
 Tumor microenvironment factors (as glucose deprivation, acidosis and hypoxia) 
induce ER stress in T-47D cancer cells; 
 ER stress strongly induces upregulation of the angiogenic factor IL8 in T-47D 
cells; 
 TERS phenomena is not observed under physiological conditions; 
 Tunicamycin is probably carried on T-47D cell-derived exosomes which directly 
induces ER stress on THP-1 cells. 
 Exosomes from glucose-deprived T-47D cells modulate THP-1 cells towards a 
particular proinflammatory profile and decreased maturation status. 
 
Additionally, parallel work has revealed some new aspects about tumor metabolism, 
namely that: 
 Lactate mitigates ER stress induced by glucose deprivation. 
 
Outlook 
It is important to clarify how tunicamycin-induced ER stress is transmitted to THP-1 
cells, namely by the direct assessment of the presence of tunicamycin within exosomes. 
This feature can reveal new protective phenomena in which cancer cells are able to 
detoxify high concentrations of cytoplasmic drugs by exosomal release. In terms of THP-1 
modulation, it is also worth to further investigate which are the mechanisms underlying the 
IL8 upregulation in THP-1; since it is a parallel characteristic of T-47D cells and IL8 
mRNA is also present in exosomes. Additionally, it still unclear and interesting to analyse 
the differential proteomics of breast cancer cells exosomes, ER stressed and unstressed. 
To conclude, it will be of great interest to evaluate how glucose/lactate metabolism 
occurs within the tumor. Tumor cells seem to be highly dynamic adapting their metabolism 
to the microenvironment features. 
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